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ABSTRACT
A transcription factor (TF) is a protein or protein complex. It regulates the
expression of its target genes by physically binding to the regulatory regions
of these genes. The binding sites of a TF naturally share a common pattern
or motif with one another. Given known binding sites of a TF, a TF model
can be built to scan sequences for putative binding sites. This is known as a
transcription factor binding site (TFBS) search problem. In this dissertation,
we investigate the TFBS search problem using machine learning approaches.
In general, the known binding sites of a TF are of variable lengths and have
to be aligned before a model can be built. Transcription factor binding site
alignment is considered an unsupervised learning problem since no other
information about the unaligned binding sites is given. We propose an al-
Chih Lee - University of Connecticut - 2014
gorithm that considers the lengths of TFBSs and dependencies of nucleotide
positions in a binding site. The novel method is named LASAGNA (Length-
Aware Site Alignment Guided by Nucleotide Association).
Studies often utilize TFBS search tools to predict the binding sites of a TF in
a DNA sequence when binding sites found by assays are not available. The
analysis often involves TF model collection, promoter sequence retrieval and
visualization, requiring several tools to accomplish. To accelerate TFBS anal-
yses, we developed a novel integrated webtool named LASAGNA-Search.
This user-friendly tool allows users to perform the analysis without leaving
the site.
TFBS search methods are considered supervised learning algorithms since
they learn from example binding sites of a TF. Most of the TFBS search meth-
ods consider only known binding sites of a TF and hence deal with one-class
classification problems. However, non-binding sites contain information
about the TF as well. When non-binding sites are available, searching for
TFBSs becomes a two-class classification problem. We propose two novel
methods named the negative-to-positive vector and the optimal discrimi-
nating vector methods, utilizing both binding sites and non-binding sites.
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Introduction
Machine Learning and Computational
Transcription Factor Binding Site Analysis
0.1 Supervised and Unsupervised Learning
Machine learning problems in general fall into two categories, supervised
learning and unsupervised learning. The classification problem is a super-
vised learning problem. In a classification problem, each data instance is
tagged with a class label. The labeled instances “supervise” the learning
process, which produces a classifier. The classifier is able to distinguish one
class from another and hence can be used to classify a data instance whose
class is unknown. A data instance in this case can be variables describing a
person, while the class labels are normal and cancer. The trained classifier
can predict if a person has cancer based on these variables. The clustering
problem, on the other hand, is a unsupervised learning problem. Each data
instance is not tagged with a class label in this case. A clustering algorithm
divides data instances into groups based on the similarity between two data
instances. One example is to group cancer patients so as to identify cancer
subtypes.
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Embedding data instances in Rp is usually a first step in machine learning,
where p is the number of variables describing an instance. For some data, an
instance is readily described by p real variables. Microarray data [75] is one
example, where each array is described by the expression of p genes. Often-
times, biological data instances are not readily described by p real variables
and hence conversion is needed to embed each instance inRp. For instance,
to manipulate sequence data in the Euclidean space, each sequence needs to
be embedded inRp. Once embedded inRp, it is often desired to manipulate
the instances in a lower dimensional subspace Rk, where k < p. A sub-
space can be found such that certain requirements are satisfied. Principal
component analysis (PCA) [39], a unsupervised learning approach, finds a
subspace such that a desired portion of variance in the data is retained in the
subspace while pairwise similarity between data instances is approximately
preserved. Previous studies showed success of PCA in population structure
analysis [46], ethnicity inference [52] and haplogroup inference [88]. With
additional information, data instances can be categorized into 2 or more
classes. In this case, data instances can be placed in a subspace found by
Fisher’s discriminant analysis (FDA), which can be viewed as a supervised
learning method. In this subspace, class centers are separated as far from
one another as possible while class members are pulled as close toward
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their respective class centers as possible. It was demonstrated that FDA can
be used to visually identify the best similarity measure between two short
DNA sequences [48] in searching for transcription factor binding sites.
PCA and FDA systematically find a subspace such that certain require-
ments are satisfied. Domain knowledge however can also be utilized to find
subspaces. Lee and Huang [49] approached the transcription factor (TF)
binding site (TFBS) search problem by first embedding short sequences of
length l or l-mers in space, where l is the length of TFBSs. TFBSs can then be
searched in subspaces identified by domain knowledge. Specifically, these
are promising subspaces implied by previous studies. Similar to informa-
tion retrieval [1], a query vector is used to search for TFBSs. Two supervised
approaches to constructing a query vector were proposed. One is named the
negative-to-positive vector (NPV) method. The other is named the optimal
discriminating vector (ODV) method. NPV and ODV are supervised meth-
ods because they learn from known TFBSs and non-TFBSs. It was shown
that, in this framework, the best subspace can be identified for each individ-
ual TF. This important advantage contributes to the superior performance
of the NPV and ODV methods to a state-of-the-art method named ULPB [69].
0.2 Computational TFBS Analysis
3
A transcription factor is a protein that regulates the expression of its target
genes by physically binding to the regulatory regions of these genes. The
binding sites of a transcription factor (TF) naturally share similarity with
one another. The common pattern shared among the binding sites of a TF is
called a motif. In general, there are two approaches to computational motif
analysis, de novo motif discovery [3, 85, 5, 11, 76, 79, 66, 4, 55, 91, 89, 29] and
transcription factor binding site (TFBS) search [63, 13, 34, 69, 24]. As the
name suggests, de novo motif discovery algorithms finds over-represented
patterns in sequences without prior knowledge of the binding TFs. The
input to these algorithms is usually the upstream region sequences of genes
putatively co-regulated by one or more common TFs. The output is one or
more motifs or patterns whose instances are over-represented in the input
sequences. On the other hand, a TFBS search algorithm takes binding site
sequences of a TF as input. It learns from these known binding sites and
builds a TF model out of them. The TF model can then be used to scan
sequences for putative binding sites. While the two approaches are tightly
connected, we focus on the TFBS search problem and assume that a TF has
known binding sites available.
0.2.1 Transcription Factor Binding Site Alignment
A typical TFBS search algorithm requires aligned TFBSs. This requirement
allows simple representations of TF models. Types of TF models include con-
4
sensus sequences, position-specific scoring matrices (PSSMs) [77], etc. The
PSSM method is a widely used method among the available TFBS search
algorithms. Given aligned binding sites of a TF, the TF model is essentially
a 4 × l matrix, where l is the length of the binding sites. Column i of the
matrix stores the scores of matching the ith letter in a sequence of length l
(an l-mer) to nucleotides A, C, G and T, respectively. The score of an l-mer is
then calculated by summing up the scores of letter 1 through letter l. Once
constructed, the matrix of a TF can be stored in a database to scan sequences
for binding sites of the TF in the future without resorting to the actual bind-
ing sites. In fact, many tools [74, 40, 71, 13, 83, 90, 41] depend on matrices
stored in at least one of the databases, JASPAR [10], RegulonDB [27] and
TRANSFAC [59]. Since a matrix is constructed from aligned binding sites,
we cannot overemphasize the quality of TFBS alignments.
Databases such as JASPAR, TRANSFAC and ORegAnno [32] contain DNA
segments bound by TFs. These DNA segments can be seen as TFBSs with
some irrelevant bases on one or both sides because of the resolutions of
techniques used to obtain TFBSs. The DNA segments belonging to a TF are
therefore unaligned variable-length sequences. While the DNA segments
for most TFs in the JASPAR database are aligned, this is not the case for the
TRANSFAC public and ORegAnno databases. About 53% (983 out of 1867)
5
of the TFs in the TRANSFAC Public database (release 7.0) have unaligned
variable-length DNA segments. Moreover, nearly 78% (1447 out of 1867) of
TFs having curated DNA segments do not have a matrix. Focusing on TFs
with variable-length DNA segments, about 71% (669 out of 983) of them do
not have a matrix. On the other hand, the ORegAnno database stores ex-
perimentally validated DNA segments bound by TFs but does not provide
matrices. About 31% (175 out of 572) of the TFs therein have variable-length
DNA segments. In the absence of a matrix, to search for binding sites of
these TFs using a matrix dependent tool, one needs to first align the cu-
rated DNA segments for each TF. In the rest of this proposal, we refer to
(variable-length) DNA segments containing TFBSs as (variable-length) TF-
BSs for simplicity reasons.
ChIP-seq data represents another important source of TFBSs. ChIP-seq [38]
is a high-throughput technique used to determine the in vivo binding affini-
ties of a transcription factor to DNA on the whole-genome scale. The raw
data from an ChIP-seq experiment is typically processed by a peak-finding
algorithm to identify DNA segments containing binding signal peaks. These
variable-length DNA segments can be seen as TFBSs with excessive irrel-
evant bases on both sides. To locate the actual TFBS within each DNA
segment, a de novo motif discovery tool can be used to identify the motifs
6
present in those DNA segments.
0.2.2 Transcription Factor Binding Site Search
One assumption the PSSM representation makes is that positions in a bind-
ing site are independent, which is often not the case. Osada et al. [63]
exploited dependence between positions by considering nucleotide pairs in
scoring methods. It was shown that incorporating nucleotide pairs signif-
icantly improved the performance of a method, meaning that most tran-
scription factors studied demonstrated correlation between positions in a
binding site. This result was reinforced in a recent study [69], in which the
authors showed correlations between two nucleotides within a binding site
by plotting the mutual information matrix. A novel scoring method called
the ungapped likelihood under positional background (ULPB) method was
proposed in this study. The ULPB method models a TFBS by two first-order
Markov chains and scores a candidate binding site by likelihood ratio pro-
duced by the two Markov chains. leave-one-out cross-validation results on
22 TFs with 20 or more binding sites showed that ULPB is superior to the
methods compared in their work.
The PSSM method and methods alike consider only known binding sites
of a TF, while information contained in non-binding sites is not exploited.
This is because explicit use of negative examples in the TFBS search prob-
7
lem is hindered by the vast amount of non-binding sites of a transcription
factor. This is further aggravated by the low specificity of some transcrip-
tion factors, where a binding site may be more similar to a non-binding
site than some other binding sites. Owing to these issues, previous studies
involving negative examples are limited and the roles of negative examples
remain unclear. In a review article, Hannenhalli [34] surveyed work on
improved motif models and integrative methods. None of these reviewed
studies [34], however, investigated the use of negative examples on top of
true TFBSs. While introducing improved benchmarks for computational
motif discovery, Sandve et al. [72] described algorithms for finding optimal
motif models using both positive and negative TFBSs. Three models were
compared using the proposed benchmarks. However, no methods relying
on only positive examples were compared. In a previous study, Do and
Wang [18] formulated the TFBS search problem as a classification problem,
proposed a novel similarity measure, and investigated three classification
techniques. Five-fold CV results showed that learning vector quantization
performed better than P-Match [13], which requires only positive examples.
The evaluation, however, was done on only 8 human transcription factors
and 8 artificial ones. It is not clear how the results on the small set of 8
real TFs can be generalized to other TFs. Lee and Huang [48] proposed to
visualize TFBS’s in the context of negative examples. It was shown that,
8
using negative examples explicitly, the visualization technique affords iden-
tification of a better similarity measure between short sequences in a TFBS
search problem.
0.2.3 Chapter Organization
In this dissertation, we investigate transcription factor binding site search
and visualization using machine learning techniques. Typically, a TFBS
search algorithm cannot process and learn from unaligned binding sites.
Therefore, the TFBS search problem consists of two sub-problems. One is
aligning the known variable-length binding sites of a TF, while the other is
searching for novel binding sites given the aligned TFBSs. TFBS alignment
can be seen as an unsupervised learning problem since no other information
about the unaligned TFBSs is given. In Chapter 1, we describe an algorithm
that considers the lengths of TFBSs and iteratively applies a TFBS search
method to scanning unaligned TFBSs [50, 51, 47]. That is, a supervised
learning algorithm is used at each iteration to deal with this unsupervised
learning problem. The method is named LASAGNA (Length-Aware Site
Alignment Guided by Nucleotide Association). We show that LASAGNA
significantly outperforms two widely used algorithms for TFBS alignment.
Coupling LASAGNA with a TFBS search method, we further show that it
performs better than an alignment-free method accepting variable-length
input TFBSs.
9
Studies often utilize TFBS search tools to predict the binding sites of a TF in
a DNA sequence when binding sites found by assays are not available. The
analysis often involves TF model collection, promoter sequence retrieval and
visualization, requiring several tools to accomplish. To accelerate TFBS anal-
yses, we developed a novel integrated webtool, allowing users to perform
the analysis without leaving the site. Important features include accepting
unaligned variable-length TFBSs, collections of 1792 TF models, automatic
promoter sequence retrieval, visualization in the UCSC Genome Browser
[19] and gene regulatory network inference/visualization based on binding
specificities. We describe this user-friendly webtool in detail in Chapter 2.
Most of the TFBS search methods consider only known binding sites of a
TF and hence deal with one-class classification problems. However, non-
binding sites contain information about the TF as well. When non-binding
sites are available, searching for TFBSs becomes a two-class classification
problem. In Chapter 3, we describe the NPV and ODV methods, which
utilize both binding sites and non-binding sites of a TF. We show the perfor-
mance gain of the NPV and ODV methods over the ULPB method through
cross-validation experiments and independent validation experiments on
the whole genome scale.
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Chapter 1
LASAGNA: An Unsupervised Learning
Algorithm for TFBS Alignment
1.1 Background
In this chapter, we describe a novel TFBS alignment algorithm named
LASAGNA (Length-Aware Site Alignment Guided by Nucleotide Asso-
ciation). The algorithm is based on the hypothesis that binding sites of a
TF share a core [12], a short and highly conserved stretch of DNA. Hence, a
binding site can be seen as a core with some irrelevant bases on one or both
sides. In general, shorter sites tend to contain fewer irrelevant bases and are
easier to align. For this reason, we progressively align the binding sites from
the shortest to the longest ones. The algorithm further exploits dependence
between two positions in a binding site. Dependence between positions
has been shown to boost performance of TFBS search algorithms [63, 69]
as well as protein structural motif recognition [44]. To our best knowledge,
this idea has never been applied to multiple sequence alignment. We further
describe a more sophisticated version, named LASAGNA-ChIP, for aligning
peak sequences produced by ChIP-seq experiments.
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To compare algorithms for TFBS alignment, we conduct cross-validation
(CV) experiments on 4771 binding sites of 189 TFs across 5 species extracted
from the TRANSFAC Public database (release 7.0). We compare LASAGNA
to ClustalW2 [81, 45] and MEME [3]. ClustalW2 [81, 45] is a widely used
multiple sequence alignment tool. It aligns sequences by first constructing a
guide tree based on pairwise sequence alignments. The guide tree then de-
termines the order in which the sequences are aligned. Although ClustalW2
was not specifically designed for aligning TFBSs, it was used to produce
gapped TFBS alignments in creating the MAPPER database [58] as well as
to produce both gapped and gapless TFBS alignments in [69]. ClustalW2
and other similar algorithms focus on producing structurally correct align-
ments, while other improved algorithms rely on structural or homology
information [61]. ClustalW2 can be viewed as a representative of these al-
gorithms when no information other than sequences is available.
MEME [3], on the other hand, is a widely adopted de novo motif discovery
tool. It is used to find over-represented patterns or motifs in input se-
quences. It is capable of locating the motif instances in each input sequence,
while it can also handle the case when an input sequence does not contain
an instance of the motif. Since the binding sites of a TF share a common
12
pattern or motif, a de novo motif discovery tool can be used to locate the
motif instance in each binding site. This shared motif can then be used to
align the binding sites. Therefore, in this dissertation, we view MEME as
a TFBS alignment tool rather than a de novo motif discovery tool. In fact,
MEME is employed by the PAZAR database [64] to dynamically align TF-
BSs and generate PSSMs. It is also used by 5 out of 6 tools compared in
[80] for ChIP-seq data analysis. We show that LASAGNA significantly out-
performs ClustalW2 (p-value: 1.22×10−15) and MEME (p-value: 3.55×10−15).
To scan promoters for new TFBSs based on variable-length known TFBSs,
we couple a PSSM method with LASAGNA, denoted by LASAGNA-PSSM.
That is, the input variable-length TFBSs are aligned by LASAGNA and
a PSSM model is built from the alignment. It is useful to compare an
alignment-based TFBS search method to an alignment-free method. There-
fore, we further compare LASAGNA-PSSM to SiTaR [24], which accepts
variable-length input TFBSs. To our best knowledge, SiTaR is the only
alignment-free method capable of handling variable-length input TFBSs
at the time of writing. Cross-validation results on 90 TFs whose binding
sites can be located in respective genomes indicate that LASAGNA-PSSM
is significantly more precise at fixed recall rates (p-value: 2.66 × 10−8). The
recall-precision curve also shows that our method is constantly more precise
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at any recall rate and more sensitive at any precision.
Finally, we demonstrate the application of LASAGNA-ChIP to ChIP-seq
data using 38 mouse ChIP-seq experiments. We show that, assuming the
one-per-sequence model, LASAGNA-ChIP is comparable to MEME in re-
vealing the motif of the ChIPed TF or its cofactor. For both LASAGNA-ChIP
and MEME, the ChIPed TF motif was found in 31 experiments, while a co-
factor motif was found in 3 experiments. While the two methods differ in
the rest 4 experiments, the found motifs have similar information content
and may belong to unknown cofactors.
1.2 Methods
We describe our novel alignment algorithm in this section. LASAGNA
utilizes a search module to align a new binding site with a partial align-
ment. Thus, we introduce the search module followed by the LASAGNA
algorithm.
1.2.1 The Search Module
The search module of LASAGNA is a function learned from a (partial) TFBS
alignment to score l-mers. It considers nucleotide pairs in addition to in-
dividual nucleotides so as to exploit dependence between positions. We
introduce our choice of the search module, the PSSM model described in
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[63]. We denote it by PSSMaK(·) in this chapter.
Suppose that a PSSM is constructed from aligned sequences of length l. The
score of letter u at position i is given by
Mi(u) = log
fi(u)
f (u)
,
where fi(u) is the probability of observing letter u at position i and f (u) is
the background probability of seeing letter u. Similarly, the score of a pair
of letters (u, v) at position (i, j) is given by
Mi, j(u, v) = log
fi, j(u, v)
f (u, v)
,
where fi, j(u, v) is the probability of observing nucleotide pair (u, v) at position
(i, j) and f (u, v) is the background probability of seeing the pair. The score
of s, a sequence of length l, is then
PSSMK(s) =
l∑
i=1
Mi(si) +
K∑
k=1
l−k∑
i=1
Mi, j(si, s j), (1.2.1)
where si denotes the ith letter of s, j = i + k and K is the scope parameter
defined in [63]. The parameter K controls how far apart a pair of nucleotides
can be. When K = 1, only adjacent nucleotide pairs are scored. We define
PSSM0(s) =
∑l
i=1 Mi(si), that is, we do not score nucleotide pairs when K = 0.
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Our search module is a variant of (1.2.1). Let
M′i(u) =

minx Mi(x) if u is the gap letter
Mi(u) otherwise
and
M′i, j(u, v) =

minx,y Mi, j(x, y) if u or v is the gap letter
Mi, j(u, v) otherwise
.
The search module is defined as follows:
PSSMaK(s) =
l∑
i=1
M′i(si) +
K∑
k=1
l−k∑
i=1
M′i, j(si, s j), (1.2.2)
where superscript a denotes alignment as this module is used in our align-
ment algorithm.
1.2.2 The LASAGNA Algorithm
The algorithm is based on the idea that the binding sites of a TF share a
common core, a conserved short DNA sequence. A binding site can then be
seen as a core with a few irrelevant bases on one or both sides. Assuming
that each binding site fully contains the core, the shorter a binding site, the
fewer irrelevant bases it contains. Therefore, we progressively align the
binding sites by aligning the shortest binding site with the already aligned
binding sites until all the binding sites are aligned.
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The algorithm takes a set of unaligned binding sites, U, and parameter Ka
as inputs. Let A denote the set of aligned binding sites. A binding site in A
may have gap letters added to one or both ends as a result of the alignment.
The algorithm works as follows:
(i) Initialize A to {s}, where s, the seed site, a shortest binding site arbitrarily
chosen from U. Remove s from U.
(ii) (a) Build PSSMaKa(·) from A. Let the length of this PSSM be l.
(b) Remove the shortest binding site s from U.
(c) Create S, the augmented sequence of s, by adding l − 1 gap letters
to both ends of s.
(d) Score each l-mer of S by PSSMaKa(·) to find the highest scoring one.
(e) Let s be its reverse-complement and repeat c–d. That is, the opposite
strand is considered.
(iii) Add s to A if the highest scoring l-mer resides in s. Otherwise, add its
reverse-complement to A. Gap letters are added to one or both ends
of sequences in A. This ensures that they are all of the same length
and each column of the alignment has at least one non-gap letter.
(iv) Repeat ii–iii until U is empty.
In step iib, there may be more than one shortest binding sites in U. To break
the tie, we use PSSMaKa(·) to scan each of the shortest ones. The “s” contain-
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Figure 1.2.1: An Illustration of LASAGNA with Ka = 0
ing the highest scoring l-mer is removed from U to align with sequences in
A. In the unlikely case of two or more shortest binding sites in U sharing
the same highest score, one is arbitrarily chosen. Figure 1.2.1 illustrates an
iteration of the algorithm.
An alignment may be trimmed before building a PSSM. We describe one
way of trimming aligned TF binding sites using two simple measures. Let
l be the length of the aligned binding sites. We first compute and denote
the percentage of non-gap letters at position i of the alignment by Ci, for
i = 1, 2, . . . , l. The information content (IC) at each position is then computed
with small sample correction described in [73]. That is,
ICi = max
0, 2 + ∑
u∈{A, C, G, T}
fi(u) log2 fi(u) − eˆ(ni)
 ,
where i ∈ {1, 2, . . . , l}, ni is the number of non-gap letters at position i and
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eˆ(·) gives the approximated sampling error. Let Cmin and ICmin be the cutoff
thresholds. The alignment is examined from the left end to the right until the
first position j satisfying both C j > Cmin and IC j > ICmin is encountered. The
positions preceding j are trimmed off. The trimming is similarly applied to
the right end.
1.2.3 LASAGNA for ChIP-seq Data
Although LASAGNA is not specifically designed as a de novo motif discovery
algorithm, a more sophisticated version, named LASAGNA-ChIP, is capa-
ble of handling ChIP-seq data. Here, we refer to the previous section and
describe the additional steps that are necessary for aligning ChIP-seq peak
sequences. The flowchart in Figure 1.2.2 gives an overview of LASAGNA-
ChIP.
Before aligning ChIP-seq peak sequences, each sequence is clipped to 100
bp surrounding the signal peak. This is a common practice since, for most
peak sequences (> 90%), the actual TFBS is usually found within 50 bp
of the called peak [38]. In step iia, we trim the partial alignment A if it
contains more than two sequences. Unlike TFBSs found in databases such
as TRANSFAC, even after clipping, a peak sequence contains much more
irrelevant bases flanking the core. The trimming procedure described in the
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Figure 1.2.2: LASAGNA-ChIP Flowchart
previous section is used, where Cmin (ICmin) is set to the mean Ci (ICi) over
all the columns of A. The resulting alignment is further trimmed by IC such
that it has at most 15 columns and the columns on both ends have positive
IC. In step iib, if there are more than 5 shortest binding sites in U. Only 5
are arbitrarily chosen to break the tie by similarity to PSSMaKa(·).
The alignment A obtained by the modified procedure is further refined as
follows:
(i) Set T to A trimmed to l columns as described above.
(ii) Build PSSMaKa(·) out of T.
(iii) Initialize R to {}, the refined partial alignment.
(iv) For each peak sequence s,
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(a) Create S, the augmented sequence of s, by adding l − 1 gap letters
to both ends of s.
(b) Score each l-mer of S by PSSMaKa(·) to find the highest scoring one.
(c) Let s be its reverse-complement and repeat a–b.
(d) Add s to R if the highest scoring l-mer resides in s. Otherwise, add
its reverse-complement to R. Gap letters are added to one or both
ends of sequences in R.
(v) Set A to R and repeat i–v until the sum of IC across columns of T does
not change in 3 iterations.
For ChIP-seq peak sequences, the shortest sequence may miss or contain
only a fraction of the core. Hence, using the shortest sequence as the seed
site sometimes results in an alignment with less IC. For this reason, five
additional sequences are arbitrarily chosen as the seed site to produce 5
additional alignments. Among the 6 alignments, the one with the most IC
after trimming is chosen as the final alignment.
1.2.4 Scoring a Putative Binding Site
Although a PSSM suggests the length of a putative binding site, we do not
restrict the length of a candidate binding site to the length of the PSSM. A
putative binding site could be of any reasonable length. If a true binding
site is flanked by a few irrelevant bases, this sequence should be given a
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relatively high score compared to those of non-binding sites. Therefore, to
score a putative binding site s, we slide s through the PSSM as described in
the previous section. The score of sequence s is given by
ScoreKs(s) = max
i∈{1,2,...,l+ls−1}
PSSMKs(Si:(i+l−1)), (1.2.1)
where l is the length of the PSSM, ls is the length of s, S denotes the augmented
sequence of s with l − 1 gap letters on both ends and PSSMKs(·) is defined in
(1.2.1).
1.3 Results and Discussion
1.3.1 Comparison of Alignment Algorithms
1.3.1.1 Data sets
We downloaded all the TF binding sites from the TRANSFAC Public database
(release 7.0). The binding sites were grouped by species and TF. Binding
sites having less than 4 nucleotides were discarded. TFs of each species
were filtered such that each TF has at least 10 binding sites. This ensures
that each TF has enough binding sites to construct a PSSM. The numbers of
TFs and TFBSs are listed in Table 1.3.1.
To facilitate experiments, we planted each TFBS in a 2000 base random
sequence simulated by a first-order Markov chain of the species in question.
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Table 1.3.1: TFBSs in TRANSFAC Public Database by Species
Species # TFs1# TFBSs2
Homo sapiens 68 1984
Mus musculus 53 966
Rattus norvegicus 26 633
Drosophila melanogaster 29 935
Saccharomyces cerevisiae 13 253
Overall 189 4771
1The total number of TFs
2The total number of TFBSs
Except for Saccharomyces cerevisiae, the Markov chain of a species was
learned from promoter sequences in the UCSC Genome Browser database
[19]. For Saccharomyces cerevisiae, the promoter sequences were retrieved
from the SCPD [93] using the yeast gene list in euGenes [30].
1.3.1.2 Performance assessment and evaluation metrics
Since the purpose of aligning TFBSs is to construct a PSSM, the quality of
an alignment is best measured by the search performance of the PSSM. The
performance of a TFBS search method is evaluated by ν-fold CV. Consider
a TF with n binding sites. The n TFBSs are first divided into ν sets, each of
which contains bnν c or bnν c + 1 TFBSs. At each iteration of the ν-fold CV, one
of the ν TFBS sets called the test TFBS set, Ptest, is left out. The rest of the
TFBSs are aligned to build a PSSM. Each test TFBS in Ptest is then planted
in a 2000 base random sequence and scanned by the PSSM, scoring each
l-mer, where l is the length of the test TFBS. We score both the forward and
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reverse strands of an l-mer and assign the higher score to it. An l-mer is
considered a hit if it shares more than bl/2c bases with the test TFBS. The
l-mers can then be divided into two sets, H and N, where H is the set of hits
and N is considered the set of non-binding sites. The score of the test TFBS
is the highest score of hits in H. For each test TFBS t ∈ Ptest, we find its rank
relative to all the non-binding sites in N. Formally, the rank of binding site
t equals 1 + |{s ∈ N|ScoreKs(s) ≥ ScoreKs(t)}|.
After the ν-fold CV, we end up with n ranks, each of which corresponds to a
TFBS. We use the area under the ROC curve (AUC) to gauge the quality of
alignment. The ROC curve is a plot of true positive rate (TPR) against false
positive rate (FPR), displaying the trade-off between TPR and FPR. We refer
readers to [23] for an introduction to this metric. In this study, ν = 10 for all
the CV experiments.
1.3.1.3 Comparison with ClustalW2
In general, gapless alignment is preferred over gapped alignment for align-
ing TFBSs. Because of the nature of ClustalW2, the alignment of TFBSs may
contain gaps in the middle of some binding sites. This is disadvantageous to
ClustalW2 as the PSSM method does not allow insertion of gaps into the se-
quence being scanned. Hence, we turned off gaps by setting the gap opening
penalty parameters to a large value, i.e., we set both GAPOPEN and PWGAPOPEN
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to 100000. Indeed, results indicated that overall the “gapped” ClustalW2
performs slightly worse than the “gapless” variant (p-value: 0.277). For both
LASAGNA and ClustalW2, parameter Ks in Eq. 1.2.1 was searched from 0 to
min{10, lmin−1} for each TF and the one producing the highest AUC is used,
where lmin is the minimal length of the TFBSs. For LASAGNA, parameter Ka
of the LASAGNA algorithm was set to Ks as the two parameters are closely
related.
We conducted 10-fold CV on each TF. The overall ROC curves are shown in
Figure 1.3.1. The ROC curves are based on the ranks of 4771 TFBSs of 189
TFs. It shows that LASAGNA has invariably higher true positive rate than
ClustalW2. The AUC score was calculated for each TF and for each method.
To gauge the significance of difference, the Wilcoxon signed-rank test [87]
was performed for each species. The tests showed that LASAGNA is consis-
tently better than ClustalW2 across the 5 species. Table 1.3.2 shows the test
results. Overall, LASAGNA performed significantly better than ClustalW2
in terms of AUC scores. The species-wise p-values shows that LASAGNA
is significantly better (< 0.05) than ClustalW2 for aligning TFBSs of all the 5
individual species.
To better understand the results, we split the 189 TFs into two groups. One
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Figure 1.3.1: Overall ROC Curves for the Three Alignment Algorithms
contains TFs on which LASAGNA performed better than ClustalW2 and the
other contains the rest of the TFs. Three factors are examined for each TF.
They are the number of TFBSs, the mean and standard deviation of TFBS
length. For each factor, we looked for difference between the two groups.
Table 1.3.3 shows the comparisons. It can be seen that LASAGNA produces
better alignments when a TF has fewer binding sites but the difference is
not significant. The mean and standard deviation of TFBS length are the
two more important factors. We believe that LASAGNA is well-suited for
aligning TFBSs that are longer and more variable in length.
1.3.1.4 Comparison with MEME
The MEME tool in the MEME Suite 4.8.1 was used. The parameter minw,
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Table 1.3.2: Species-wise and Overall Comparisons between LASAGNA and
ClustalW2
Species # better1# ties2# TFs3 p-value4
H. sapiens 54 (79.4%) 0 68 4.42 × 10−7
M. musculus 42 (79.2%) 0 53 1.41 × 10−5
D. melanogaster 22 (75.9%) 0 29 9.89 × 10−4
S. cerevisiae 9 (69.2%) 1 13 3.88 × 10−2
R. norvegicus 20 (76.9%) 1 26 1.54 × 10−3
Overall 147 (77.8%) 2 1891.22 × 10−15
1Number of TFs on which LASAGNA performs better than ClustalW2.
2Number of TFs on which LASAGNA and ClustalW2 have the same performance.
3Total number of TFs for a species.
4Wilcoxon signed-rank test p-value.
minimal width of motifs, was set to the smaller of 6 and the minimal length
of input TFBSs. The option revcomp to search the reverse strand was turned
on. Finally, the parameter minsites was set to the number of input TFBSs
since a common motif is supposed to appear at least once in each TFBS. To
ensure that MEME functions properly, binding sites shorter than 8 bases are
padded with gap letters since genomic locations are not available for most
TFBSs.
The experiments were carried out in the same manner as the ClustalW2 ex-
periments. The overall ROC curve in Figure 1.3.1 indicates that LASAGNA
has consistently higher true positive rates than MEME across different
false positive rates. The overall and species-wise comparisons between
LASAGNA and MEME in Table 1.3.4 show that LASAGNA performed sig-
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Table 1.3.3: Comparison of Two Groups of TFs Divided According to Results
on LASAGNA and ClustalW2
Factor Group 11 meanGroup 22 meanp-value3
# TFBSs4 25.07483 25.83333 0.1409
Mean of TFBS length 18.78626 17.56167 0.08451
SD of TFBS length5 8.180204 6.921905 0.06295
1LASAGNA performed better than ClustalW2 on TFs in this group.
2ClustalW2 performed better than or equal to LASAGNA on TFs in this group.
3Wilcoxon signed-rank test p-value.
4Number of binding sites for each TF.
5Standard deviation of binding site length for each TF.
nificantly better than MEME. To gain some insights into the difference be-
tween LASAGNA and MEME, we similarly examined the three factors used
to compare LASAGNA and ClustalW2. As seen in Table 1.3.5, the number
of input TFBSs is the only significant (p-value < 0.05) factor out of the three.
The reasons are not clear but may be investigated in the future. Moreover,
it will be helpful to identify other (biologically meaningful) factors that can
better explain the performance difference.
1.3.1.5 Distribution of Ks
In Figures 1.3.2, 1.3.3 and 1.3.4, for LASAGNA, ClustalW2 and MEME, we
show the distribution of Ks for a TF by species and conserved domain. Over-
all, we observe that small values are preferred for all three methods. By vi-
sual inspection, LASAGNA appears more similar to MEME than ClustalW2
in the usage of Ks. It can be seen that the usage of Ks differs among different
conserved domains. Related conserved domains such as ZF-H2C2 2 and
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Table 1.3.4: Species-wise and Overall Comparisons between LASAGNA and
MEME
Species # better1# ties2# TFs3 p-value4
H. sapiens 41 (60.3%) 0 68 7.83 × 10−3
M. musculus 41 (77.4%) 0 53 8.79 × 10−6
D. melanogaster 26 (89.7%) 0 29 1.02 × 10−7
S. cerevisiae 10 (76.9%) 3 13 2.96 × 10−3
R. norvegicus 23 (88.5%) 1 26 1.73 × 10−4
Overall 141 (74.6%) 4 1893.55 × 10−15
1Number of TFs on which LASAGNA performs better than ClustalW2.
2Number of TFs on which LASAGNA and ClustalW2 have the same performance.
3Total number of TFs for a species.
4Wilcoxon signed-rank test p-value.
ZF-C2H2 display similar patterns. This is not surprising as conserved do-
mains in a protein are often computationally predicted. Hence, a protein is
likely to possess related conserved domains. While overall the distributions
seem method-dependent, we observe that, for ZF-H2C2 2 and ZF-C2H2,
the distributions center around 4 across all three methods. Finally, we note
that these observations are preliminary and more TFs are needed to draw
statistically sound conclusions.
1.3.2 Comparison of TFBS Search Methods
1.3.2.1 Data sets
To compare with an alignment-free TFBS search method, SiTaR, [24], we
retrieved real promoter sequences embedding TFBSs. Specifically, we fol-
lowed the curated location of each binding site in the TRANSFAC Public
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Table 1.3.5: Comparison of Two Groups of TFs Divided According to Results
on LASAGNA and MEME
Factor Group 11 meanGroup 22 meanp-value3
# TFBSs4 23.33333 30.85417 0.03196
Mean of TFBS length 18.33468 19.04125 0.3007
SD of TFBS length5 7.95844 7.730625 0.1846
1LASAGNA performed better than ClustalW2 on TFs in this group.
2ClustalW2 performed better than or equal to LASAGNA on TFs in this group.
3Wilcoxon signed-rank test p-value.
4Number of binding sites for each TF.
5Standard deviation of binding site length for each TF.
database (release 7.0) to retrieve the 1000-base sequences flanking the bind-
ing site. We discarded binding sites that cannot be found in the proximity
of the curated locations. The retrieved binding sites were grouped by TF
and TFs having less than 10 binding sites were removed. After filtering, we
ended up with 90 TFs and 1751 binding sites. A TF may be present in more
than one species as homologs and hence the binding sites of a TF may be
located in genomes of multiple species. The species and respective numbers
of binding sites are shown in Table 1.3.6.
1.3.2.2 Performance assessment and evaluation metrics
To compare with SiTaR [24], we adopt the same ν-fold CV process used
to compare LASAGNA with ClustalW2 and MEME. However, we do not
assume that a TFBS search method scores all the l-mers in a promoter se-
quence, where l is the length of binding sites. Instead, a TFBS search method
scans a promoter sequence and predicts a list of binding sites with respective
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Table 1.3.6: Distribution of the 1751 Binding Sites of 90 TFs in TRANSFAC
Public Database
Species # TFBSs1
Homo sapiens 735
Mus musculus 346
Rattus norvegicus 278
Saccharomyces cerevisiae 158
Drosophila melanogaster 155
Gallus gallus 73
Bos taurus 5
Sus scrofa 1
1Total number of TFBSs.
scores. The predicted binding sites may be of different lengths, which is the
case for SiTaR.
We describe how a hit is determined. Let the length of a predicted binding
site be l and the length of the test TFBS in question be ls. The predicted
binding site is considered a hit to the test TFBS if the overlap between the
two sequences is more than bls/2c bases as in [24]. In case this is not possible,
i.e., l ≤ bls/2c, the predicted binding site must be embedded in the true one
to be deemed a hit.
Using the n ranks of TFBSs from ν-fold CV, we compute recall (true positive
rate), precision and the Fβ-measure, where β = 0.5 as in [24]. Let the recall
rate be r. The number of TFBSs recalled by the method is pT = n × r. Let
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the number of non-binding sites or false positives introduced be pF. The
precision is given by pTpT+pF , while Fβ = (1 + β
2) precision×recallβ2×precision+recall .
1.3.2.3 Comparison with an alignment-free method
We conducted 10-fold CV on the aforementioned 90 TFs. The PSSM method
dependent on LASAGNA (LASAGNA-PSSM) was compared to SiTaR [24].
LASAGNA considered both strands of a sequence when aligning binding
sites. The parameters Ka = Ks were determined in the same way as in
comparing LASAGNA to ClustalW2. An alignment was trimmed with
Cmin = 0.4 and ICmin = 0 before constructing a PSSM as described in the
method section on the LASAGNA algorithm. The PSSM method uses a cut-
off score to predict TFBSs. The cutoff score is set to the minimal score of the
constituting binding sites of the PSSM. The SiTaR method has a mismatch
parameter and the maximal value allowed by its webtool is 5. We searched
in the range from 0 to 5 to find the mismatch value giving the highest Fβ-
measure for each TF.
In terms of the Fβ, no significant difference was found between the two meth-
ods (p-value: 0.392 [87]). To ensure a fair comparison, we fixed the recall
rate for each TF and compare the precision achieved by LASAGNA-PSSM
and SiTaR. The recall rate was set to the lower of the recall rates attained by
LASAGNA-PSSM and SiTaR. The TF c-Jun (AC: T00132) was excluded from
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comparison because SiTaR did not recover any TFBS. Figure 1.3.5a shows
the plot of precision by LASAGNA-PSSM against that by SiTaR. At fixed
recall rates, LASAGNA-PSSM is more precise than SiTaR on 65 out of 89
TFs (p-value: 2.66× 10−8). Figure 1.3.5b shows the plots of precision against
recall based on all the recalled TFBSs by each method. It can be seen that
LASAGNA-PSSM is constantly more precise than SiTaR at the same recall
rate. Moreover, LASAGNA-PSSM recovered substantially more TFBSs than
SiTaR at the same precision.
Results reported in [24] showed that SiTaR is highly precise and sensitive.
Although SiTaR accepts variable-length binding sites, all the experiments
presented in [24] used fixed-length binding sites as inputs. It is therefore
not clear how SiTaR performs on TFs having variable-length binding sites. It
is also not clear whether SiTaR preprocesses highly variable-length binding
sites as this was not stated in [24]. These issues however are not the focus
of this dissertation.
1.3.3 Application of LASAGNA-ChIP to ChIP-seq Data
To demonstrate the use of LASAGNA-ChIP on ChIP-seq data, we retrieved
mouse ChIP-seq data produced by the Encyclopedia of DNA Elements
(ENCODE) project [14] from the UCSC Genome Browser [19]. All the 38 peak
files in the Narrow Peaks format that matches pattern ftp://hgdownload.
33
cse.ucsc.edu/goldenPath/mm9/database/wgEncode*Tfbs*Pk*were down-
loaded on Oct. 12, 2012, where “*” is the wildcard character matching zero
or more characters. These files give signal peak location besides start and
end for each peak and hence the corresponding signal files do not need to be
processed by a peak-finding algorithm. Four distinct cell types and 17 dis-
tinct target TFs are present in the 38 ChIP-seq experiments. Table 1.3.7 lists,
for each ChIP-seq experiment, the cell, target TF, number of peaks as well as
the minimum, maximum, mean and standard deviation of peak length. We
observe that the peak length varies greatly. The mean peak length can be as
long as 1124, while the highest standard deviation is nearly 876.
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Figure 1.3.2: Distribution of Ks by Species and Conserved Domain
(LASAGNA)
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Figure 1.3.3: Distribution of Ks by Species and Conserved Domain
(ClustalW2)
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Figure 1.3.4: Distribution of Ks by Species and Conserved Domain (MEME)
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It is useful to know if LASAGNA-ChIP is able to align peak sequences
and reveal the motif of the ChIPed TF. To align peak sequences, parameter
Ka was searched from 0 to 8 to obtain the alignment with the highest IC.
MEME was also used to align peak sequences because it is often the choice
of method. In fact, MEME is used by 5 out of 6 tools compared in [80]
for ChIP-seq data analysis. The MEME parameters are described in section
Comparison of alignment algorithms, where the one-per-sequence model is
assumed. To ensure that both methods finish within reasonable time, for
each experiment, we randomly sampled 300 peaks for alignment. We did
not distinguish large peaks from small ones because ChIP-seq experiments
require large numbers of cells and hence “a small peak could represent very
strong binding in only a subset of the cells” [22].
For each alignment, we searched for the resulting motif in 386 UniPROBE
mouse motifs and 398 motifs derived from all the matrices in the TRANS-
FAC Public database. The search was accomplished by software TOMTOM
[33]. We used Pearson correlation as the distance measure, required a min-
imal overlap of 5 nucleotides, and set the E-value cut-off to 5. Table 1.3.8
shows, for each ChIP-seq experiment, the sequence logos of motifs found by
LASAGNA-ChIP and MEME. The matching motifs found by TOMTOM are
listed under each sequence logo [15] by E-value. In case more than 10 signif-
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icant motifs were found, only the 10 most significant ones were shown. For
each ChIP-seq experiment, the one matching the ChIPed TF is highlighted
in yellow, while the one matching a cofactor of the ChIPed TF is highlighted
in blue if the ChIPed TF is not found.
We first notice that overall the motifs found by LASAGNA-ChIP and MEME
are very similar by visual inspection. No significant difference is observed in
terms of motif IC (p-value: 0.1252). For both LASAGNA-ChIP and MEME,
the ChIPed TF motifs were found for 31 experiments. Among the other 7
experiments are one MYB in MEL cells, all the ETS1 in CH12 and MEL cells,
one JUND in MEL cells, one MAX in C2C12 cells, all the TBP in CH12 and
MEL cells. Interestingly, LASAGNA-ChIP and MEME differ only for 4 out
of these 7 experiments. They are one ETS1 in CH12 cells, one MAX in C2C12
cells and two TBP in CH12 and MEL cells. Although LASAGNA-ChIP and
MEME differ in these cases, the found motifs still warrant further analyses.
For instance, the motif for ETS1 in CH12 cells found by LASAGNA-ChIP
resembles the secondary motif of Gabpa (highlighted in green), which is a
known paralog.
For the other 3 out of the 7 experiments, LASAGNA-ChIP and MEME pro-
duced similar motifs. The one found for MYB in MEL resembles those
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of GATA proteins. This agrees with a recent study reporting that MYB
and GATA-3 cooperatively regulate IL-13 by direct binding to a conserved
GATA-3 response element [42]. Since this motif is based on 300 peak se-
quences, it is likely that the two proteins similarly regulate other genes in
MEL cells. The motif for ETS1 in MEL cells also matches those of GATA pro-
teins. Cooperation between ETS1 and GATA-3 in regulating IL-5 was also
suggested [9, 86]. Finally, while the motif for JUND in MEL cells matches
two motifs in the TRANSFAC and UniPROBE databases, the matches are
likely false positives since no literature support was found.
While it is not specifically designed to be a de novo motif discovery method,
LASAGNA-ChIP aligns all the peak sequences and finds the most informa-
tive motif. The assumption that a motif instance is present in each peak
sequence may not hold for some experiments. Because of several possi-
ble binding models [22], two or more motifs may be present in subsets of
the peak sequences. Discovery of more than one motif will be enabled for
LASAGNA-ChIP in the near future.
Table 1.3.8: Sequence Logos of Motifs Found by LASAGNA-ChIP and
MEME
TF Cell LASAGNA-ChIP MEME
wgEncodeSydhTfbsMelBhlhe40cIggrabPk
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Table 1.3.8 – continued from previous page
TF Cell LASAGNA-ChIP MEME
BHLHE40 MEL
IC: 7.14 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
C
T
A
G
T
C
T
C
G
5
TCTGGTCAGTC
USF; SREBP-1; Arnt;
Bhlhb2 primary; N-Myc;
c-Myc:Max; Max; PHO4;
Max primary; MyoD; GBP;
RAV1; PIF3
IC: 7.21 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
G
A
T
A
G
G
A
CA
5
A
G
C
C
A
G
G
A
T
C
A
T
G
USF; Arnt; N-Myc; SREBP-
1; c-Myc:Max; MyoD;
Max; Bhlhb2 primary;
Max primary; PHO4; PIF3;
Sn; E47; Lmo2complex;
GBP; Myf6 primary
wgEncodeSydhTfbsCh12Bhlhe40nb100IggrabPk
BHLHE40 CH12
IC: 8.32 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
C
T
GC
T
A
A
G
C
5
A
G
G
T
C
T
G
G
T
C
A
T
A
G
C
c-Myc:Max; Arnt; USF;
Bhlhb2 primary; N-Myc;
SREBP-1; Max; PIF3; GBP;
Max primary; Hairy; PHO4;
RAV1; Max secondary;
MyoD; Zscan4 primary;
Lmo2complex;
Tcfe2a primary; E47
IC: 8.19 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
A
G
T
G
C
G
T
C
A
G
T
C
5
T
C
G
A
T
T
G
T
G
A
C
USF; Arnt; c-Myc:Max;
Bhlhb2 primary; SREBP-
1; Max; Max primary;
N-Myc; PIF3; RAV1;
PHO4; Max secondary;
GBP; Hairy; MyoD; Zs-
can4 primary
wgEncodeCaltechTfbsC2c12CebpbFCntrl50bE2p60hPcr1xPkRep1
CEBPB C2C12
IC: 10.41 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
G
ATGTATG
5
C
C
G
T
A
A
C
TC
A
T
A
10
G
C
T
C/EBPbeta; C/EBP;
C/EBPalpha; HLF; VBP;
E4BP4; Mafb secondary;
CHOP:C/EBPalpha;
ces-2; Dlx2 2273.2;
Mafk secondary;
Cphx 3484.1; Hdx 3845.3
IC: 10.4 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
G
A
C
TGTATG
5
C
C
G
T
A
A
C
TC
A
G
T
A
10
G
C
T
C/EBPbeta; C/EBP;
C/EBPalpha; HLF; VBP;
E4BP4; Mafb secondary;
CHOP:C/EBPalpha;
ces-2; Dlx2 2273.2;
Mafk secondary;
Cphx 3484.1
wgEncodeCaltechTfbsC2c12CebpbFCntrl50bE2p60hPcr1xPkRep2
Continued on next page
46
Table 1.3.8 – continued from previous page
TF Cell LASAGNA-ChIP MEME
CEBPB C2C12
IC: 9.56 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
G
A
A
G
TTG
C
T
G
A
5
G
C
T
T
G
A
T
C
C
A
C
G
A
10
A
G
C
T
T
C
A
15
C/EBPbeta; C/EBP;
C/EBPalpha; VBP; HLF;
CHOP:C/EBPalpha;
E4BP4; Mafb secondary;
Zfp105 secondary; MATa1;
Dlx2 2273.2; ces-2;
Bsx 3483.2; CREB; Oct-
1; Cphx 3484.1; Hdx 3845.3;
Gmeb1 primary
IC: 9.79 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
A
T
G
G
C
A
G
A
TTG
5
C
T
G
A
A
G
C
T
T
C
G
T
A
C
C
A
10
C
G
A
A
G
C
T
A
C/EBPbeta; C/EBP;
C/EBPalpha; VBP; E4BP4;
CHOP:C/EBPalpha;
HLF; CREB; MATa1;
Mafb secondary;
Cphx 3484.1; ces-2
wgEncodeCaltechTfbsC2c12CebpbFCntrl50bPcr1xPkRep1
CEBPB C2C12
IC: 10.39 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
G
A
G
TGTATG
5
C
T
G
C
A
A
T
C
C
A
C
G
T
A
10
G
C
T
C/EBPbeta; C/EBP;
C/EBPalpha; HLF;
Mafb secondary;
CHOP:C/EBPalpha; E4BP4;
ces-2; VBP; Dlx2 2273.2;
Hdx 3845.3; Hoxa6 1040.1;
Zfp105 secondary;
Mafk secondary
IC: 10.49 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
G
ATGTATG
5
A
C
T
G
C
A
A
T
C
C
A
T
A
10
G
C
T
A
T
C
C/EBPbeta; C/EBPalpha;
C/EBP; HLF;
Mafb secondary; E4BP4;
ces-2; CHOP:C/EBPalpha;
VBP; Dlx2 2273.2;
Hoxa6 1040.1
wgEncodeSydhTfbsCh12CjunIggrabPk
JUN CH12
IC: 8.0 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
A
T
C
A
G
T
T
C
A
G
G
C
T
A
5
T
C
GTC
C
AGCT
10
G
A
C
T
C
G
A
T
A
G
T
C
G
A
C
T
AP-1; GCN4; TCF11:MafG;
cap; Jundm2 secondary;
TCF11; Bach2; NF-E2; Dfd;
CRP; v-Maf; Six4 2860.1
IC: 7.91 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
G
C
A
G
A
T
T
C
A
G
5
G
A
A
G
C
G
A
T
A
G
C
T
A
10
C
T
A
G
G
T
C
A
15
AP-1; Jundm2 secondary;
GCN4; NF-E2;
TCF11:MafG; v-
Maf; Six4 2860.1;
Atf1 secondary; Bach2
wgEncodeSydhTfbsMelCmybh141IggrabPk
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TF Cell LASAGNA-ChIP MEME
MYB MEL
IC: 8.2 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
C
T
G
T
C
C
T
A
C
T
5
T
G
C
A
G
A
T
T
A
G
C
C
A
T
A
C
T
G
10
A
G
T
C
T
A
C
C
T
A
T
G
C
GATA-1; GATA-
2; Gata5 primary;
Gata6 primary; GATA-6;
Gata3 primary ; GATA-3;
mtTFA; Lmo2complex;
Gata3 secondary; GATA-
X; Evi-1; Bbx secondary;
Gabpa secondary; NIT2
IC: 8.21 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
5
T
A
G
T
A
G
C
T
A
10
A
C
G
C
T
A
A
C
G
T
T
G
AGA
15
A
C
G
GATA-1; GATA-
2; Gata3 primary
; Gata6 primary;
Gata5 primary; GATA-
3; GATA-6; Lmo2complex;
Gata3 secondary; mt-
TFA; GATA-X; Evi-
1; Gabpa secondary;
Sox7 secondary; NIT2
wgEncodeSydhTfbsMelCmybsc7874IggrabPk
MYB MEL
IC: 8.17 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
C
T
G
A
T
C
C
A
G
T
A
5
C
G
A
T
A
C
G
A
T
C
G
A
T
C
10
C
G
T
A
c-Myb; Myb secondary;
Ovo; Mybl1 secondary;
v-Myb; GAmyb
IC: 8.23 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
T
C
C
A
T
G
A
A
C
5
C
G
A
T
T
C
G
A
T
C
A
T
C
Mybl1 secondary;
Myb secondary; c-Myb;
Ovo; GAmyb; v-Myb;
MyoD; MIF-1
wgEncodeSydhTfbsCh12CmycIggrabPk
MYC CH12
IC: 7.96 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
G
C
A
C
T
G
A
5
A
G
C
G
C
G
T
A
A
G
C
G
A
10
A
C
G
T
A
T
G
A
T
C
G
15
Max primary; c-Myc:Max;
USF; Arnt; Max;
Tcfe2a secondary; N-
Myc; Tal-1beta:E47;
Lmo2complex; Tal-
1alpha:E47; Tal-
1beta:ITF-2; PHO4;
PIF3; Tcfe2a primary;
Sn; Myf6 primary;
Bhlhb2 secondary; E47;
Ascl2 primary; MyoD
IC: 7.98 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
A
G
C
G
A
C
G
T
A
5
A
G
C
C
G
A
G
A
TG
T
C
G
10
C
A
G
Max primary; c-
Myc:Max; USF; N-Myc;
Lmo2complex; PHO4; Max;
Arnt; Tcfe2a secondary;
MyoD; Sn; RAV1; PIF3;
Tcfe2a primary; Tal-
1alpha:E47; Tal-1beta:E47;
E47; GBP; Ascl2 primary;
Tal-1beta:ITF-2
Continued on next page
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TF Cell LASAGNA-ChIP MEME
wgEncodeSydhTfbsMelCmycIggrabPk
MYC MEL
IC: 8.44 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
G
A
C
T
G
A
T
A
C
GC
5
T
A
A
G
C
G
A
G
A
C
T
T
A
G
10
A
C
T
G
c-Myc:Max; Max primary;
N-Myc; Max; USF;
PHO4; Arnt; PIF3;
GBP; Lmo2complex;
Tcfe2a secondary; MyoD;
Bhlhb2 secondary;
Sn; Tcfe2a primary;
Max secondary; Hairy
IC: 8.45 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
T
A
G
C
A
C
G
T
A
5
A
G
C
G
A
G
C
A
T
A
G
A
C
T
G
c-Myc:Max; Max primary;
PHO4; Max; N-Myc;
USF; Arnt; GBP; PIF3;
Lmo2complex; MyoD;
Bhlhb2 secondary; Sn;
Tcfe2a secondary
wgEncodeSydhTfbsCh12Ets1IggrabPk
ETS1 CH12
IC: 7.58 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
A
C
T
G
A
C
T
G
T
C
T
A
C
5
G
A
T
A
C
G
C
A
T
T
G
C
A
T
C
10
G
A
T
C
G
A
T
T
G
C
A
T
15
C
A
T
G
Irf6 secondary;
Sox12 secondary;
Gabpa secondary ;
Ascl2 secondary; p300;
MEIS1; cap
IC: 7.99 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
C
T
G
A
C
T
A
G
C
T
A
G
C
T
5
G
T
CATTCGGACTGCT
10
A
G
T
C
A
T
C
A
C
T
G
C
T
A
G
T
C
15
G
A
C
T
RAV1; cap; Ovo; ISRE;
Tcf3 secondary; p300;
Sox4 primary
wgEncodeSydhTfbsMelEts1IggrabPk
ETS1 MEL
IC: 8.63 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
T
G
C
A
C
T
C
T
T
A
5
G
TC
C
A
T
A
C
T
G
G
A
T
C
GATA-1; GATA-2;
Gata6 primary; GATA-6;
GATA-3 ; Gata5 primary;
Lmo2complex; mtTFA;
Gata3 primary; Evi-1;
GATA-X; Gata3 secondary;
NIT2
IC: 8.71 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
C
T
A
G
T
G
A
CT
A
5
GCACGATTGATGA
10
T
C
A
G
T
C
A
G
GATA-1; GATA-
2; Gata6 primary;
Gata5 primary; GATA-6;
GATA-3 ; Gata3 primary;
GATA-X; mtTFA;
Lmo2complex; Evi-1;
Gata3 secondary
wgEncodeCaltechTfbsC2c12Fosl1sc605FCntrl36bPcr1xPkRep1
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TF Cell LASAGNA-ChIP MEME
FOSL1 C2C12
IC: 11.59 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
G
A
C
A
T
C
T
G
G
C
A
5
T
C
C
T
T
A
C
T
A
C
G
T
GCN4; Bach2; AP-1;
Bach1; Jundm2 secondary;
NF-E2; TCF11:MafG;
v-Maf; Tax/CREB;
Zfp691 secondary
IC: 11.19 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
G
A
G
C
T
T
C
G
C
A
5
T
G
C
A
C
T
T
A
C
T
A
C
T
G
AP-1; NF-E2; Bach2;
GCN4; Jundm2 secondary;
Bach1; TCF11:MafG; v-Maf;
Tax/CREB
wgEncodeSydhTfbsMelGata1Dm2p5dStdPk
GATA1 MEL
IC: 9.22 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
A
T
G
C
C
T
A
C
G
5
ACGT
C
T
G
A
C
T
G
A
T
C
A
G
10
T
C
G
A
GATA-2; GATA-1;
Gata6 primary; GATA-
3; GATA-6; Gata5 primary;
Gata3 primary; mtTFA;
GATA-X; Lmo2complex;
Evi-1; Gata3 secondary;
NIT2
IC: 9.2 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
A
T
G
CT
A
C
G
5
T
C
A
C
G
T
T
G
A
T
G
A
T
C
A
G
10
T
C
G
A
GATA-2; GATA-1;
Gata6 primary; GATA-
3; GATA-6; Gata3 primary;
Gata5 primary; mt-
TFA; GATA-X;
Lmo2complex; Evi-1;
NIT2; Gata3 secondary
wgEncodeSydhTfbsMelGata1IggratPk
GATA1 MEL
IC: 9.52 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
A
C
T
G
C
T
A
G
T
C
C
T
5
A
G
T
C
A
C
T
G
CAT
10
T
A
C
G
GATA-1; Gata6 primary;
GATA-2; GATA-
X; Gata5 primary;
Gata3 primary; GATA-
3; GATA-6; mtTFA;
Lmo2complex; Evi-1;
NIT2
IC: 9.5 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
G
CT
A
C
G
G
A
5
C
A
G
T
C
T
A
T
G
A
T
C
A
G
G
A
10
C
T
G
A
GATA-1; Gata6 primary;
GATA-2; GATA-
X; Gata3 primary;
Gata5 primary; GATA-
3; GATA-6; mtTFA;
Lmo2complex; Evi-1;
NIT2; qa-1F
wgEncodeSydhTfbsCh12JundIggrabPk
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TF Cell LASAGNA-ChIP MEME
JUND CH12
IC: 7.97 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
G
C
A
A
TG
C
G
A
5
G
A
C
G
A
T
A
T
C
C
T
A
AP-1; Bach2; TCF11:MafG;
GCN4; NF-E2; v-Maf;
Bach1; Jundm2 secondary;
Mafb primary;
Mafk primary
IC: 8.37 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T A
5
T
C
A
G
C
T
G
A
C
T
G
A
G
C
A
G
A
T
10
A
C
G
T
G
C
A
A
G
C
G
A
T
T
A
G
C
15
T
C
A
AP-1; GCN4; TCF11:MafG;
Jundm2 secondary;
Bach2; NF-E2; Bach1;
TCF11; v-Maf; cap; Dfd;
Zfp691 secondary
wgEncodeSydhTfbsMelJundIggrabPk
JUND MEL
IC: 16.59 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
G
C
A
T
A
C
G
G
C
T
A
T
C
A
G
5
T
C
G
A
C
A
T
G
T
G
A
T
C
A
G
G
T
A
10
T
A
G
C
G
A
A
T
C
G
G
T
A
C
G
15
C
A
p300; Irf6 secondary
IC: 14.47 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
G
T
A
A
T
C
G
C
T
G
A
T
A
C
G
5
T
G
A
A
C
G
T
C
G
A
T
A
G
T
G
A
10
T
A
C
G
C
G
T
A
T
A
C
G
C
G
T
A
A
C
G
15
C
G
A
Irf6 secondary; p300
wgEncodeSydhTfbsEse14MafkStdPk
MAFK ES-E14
IC: 13.47 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
C
T
A
G
C
T
A
G
C
A
T
5
T
C
G
T
G
A
C
C
A
T
C
T
G
G
C
T
A
10
A
T
C
G
A
G
C
T
G
A
T
C
C
G
T
A
C
A
T
G
15
A
T
G
C
v-Maf; TCF11:MafG;
NF-E2; Mafb primary;
AP-1; Mafk primary;
Jundm2 secondary; Bach2;
GCN4; Bach1; AP-4
IC: 13.47 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
T
G
A
C
G
C
A
T
T
C
A
G
5
T
C
G
A
T
A
G
C
G
C
A
T
A
C
G
T
A
10
A
C
T
G
A
G
C
C
G
T
A
A
G
C
G
A
T
15
C
G
A
T
v-Maf; TCF11:MafG;
NF-E2; Mafb primary;
AP-1; Mafk primary;
Jundm2 secondary; Bach2;
GCN4; Bach1; AP-4; XFD-3
wgEncodeSydhTfbsMelMafkDm2p5dStdPk
MAFK MEL
IC: 13.14 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
T
G
A
C
G
C
A
T
C
A
T
G
5
C
T
G
A
A
G
C
C
G
A
T
A
G
C
T
G
A
10
T
G
A
T
G
C
G
T
A
T
C
A
G
C
G
A
T
15
G
C
A
T
v-Maf; TCF11:MafG;
NF-E2; Mafb primary;
AP-1; Jundm2 secondary;
Mafk primary; Bach2;
GCN4; Bach1; AP-4
IC: 13.01 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
T
G
A
C
G
A
C
T
C
A
T
G
5
T
C
G
A
A
G
C
C
G
A
T
T
A
G
C
G
T
A
10
C
T
G
T
G
C
C
G
T
A
C
G
A
T
15
G
C
A
T
v-Maf; TCF11:MafG; NF-E2;
AP-1; Mafb primary;
Jundm2 secondary;
Mafk primary; Bach2;
GCN4; Bach1; AP-4
wgEncodeSydhTfbsCh12Mafkab50322IggrabPk
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MAFK CH12
IC: 8.76 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
G
T
A
C
G
C
A
T
C
T
A
G
5
C
G
T
A
T
A
C
G
C
G
A
T
G
A
C
T
A
10
T
G
T
G
C
G
C
T
A
C
G
A
T
15
C
G
A
T
v-Maf; Mafb primary;
Mafk primary;
TCF11:MafG; AP-1; NF-
E2; Jundm2 secondary;
AP-4; XFD-3; RAV1;
Zic2 secondary
IC: 8.7 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
T
A
T
T
A
C
G
5
G
T
A
C
G
C
A
T
T
A
G
G
T
C
A
T
A
G
C
10
G
C
A
T
A
C
T
A
A
T
C
G
T
G
A
C
15
C
T
A
v-Maf; Mafb primary;
TCF11:MafG; AP-1;
NF-E2; Mafk primary;
Zic2 secondary;
Zic1 secondary;
Zic3 secondary;
Jundm2 secondary; AP-
4
wgEncodeSydhTfbsMelMafkab50322IggrabPk
MAFK MEL
IC: 8.65 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
C
T
A
G
C
A
T
T
C
G
C
A
T
5
A
T
G
A
T
G
C
C
A
T
C
T
A
G
G
T
A
10
A
T
C
G
C
G
A
T
G
A
T
C
G
C
T
A
C
A
T
G
15
A
T
G
C
v-Maf; TCF11:MafG;
Mafb primary; NF-E2;
AP-1; Mafk primary;
Jundm2 secondary; Bach2;
C/EBP
IC: 8.43 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
G
A
T
C
T
A
G
G
C
T
A
T
A
G
C
5
C
A
T
G
T
A
C
T
A
T
C
A
G
T
G
A
C
10
G
C
T
A
G
T
A
C
G
A
T
G
C
A
T
A
T
15
T
TCF11:MafG;
Mafb primary;
Mafk primary; v-Maf; NF-
E2; AP-1; Zic3 secondary;
Zic2 secondary;
Jundm2 secondary;
Zic1 secondary; C/EBP;
Pbx1 3203.1; AP-4
wgEncodeCaltechTfbsC2c12MaxFCntrl50bE2p60hPcr1xPkRep1
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MAX C2C12
IC: 7.76 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
T
C
A
G
G
T
CC
5
T
A
G
C
T
C
G
A
G
A
T
C
T
G
10
C
A
T
G
USF; c-Myc:Max; Max;
Max primary; GBP;
N-Myc; Arnt; PIF3;
PHO4; Tcfe2a secondary;
Max secondary;
Lmo2complex; MyoD;
RAV1; Bhlhb2 primary;
SREBP-1; Sn
IC: 7.96 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
G
A
C
T
A
G
T
A
G
C
C
5
T
A
A
G
C
T
C
G
A
A
G
C
T
C
A
T
G
10
A
C
T
G
A
G
T
C
USF; c-Myc:Max; N-Myc;
Max; Max primary; Arnt;
GBP; Tcfe2a secondary;
PIF3; PHO4; Lmo2complex;
MyoD; Max secondary;
Myf6 primary; RAV1; Tal-
1alpha:E47; Tal-1beta:E47;
Tcfe2a primary; Sn; Tal-
1beta:ITF-2
wgEncodeCaltechTfbsC2c12MaxFCntrl50bPcr1xPkRep1
MAX C2C12
IC: 7.67 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
C
T
C
GC
T
G
A
C
5
G
AG
A
T
G
C
G
A
CA
10
T
C
G
A
G
C
A
T
C
G
A
T
C
G
Gabpa secondary;
Hic1 secondary; NF-1;
AP-1; Smad3 primary;
MyoD; Tcfap2a secondary;
Tcfe2a secondary; AP-
2alpha
IC: 7.91 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
T
G
C
A
C
T
A
T
C
G
G
A
T
C
5
G
C
T
G
C
T
A
G
T
C
T
A
C
C
T
A
10
C
T
G
G
T
C
A
T
C
G
T
C
A
G
C
T
15
T
G
C
Ascl2 secondary;
Gabpa secondary; cap;
Pax-4
wgEncodeSydhTfbsCh12MaxIggrabPk
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TF Cell LASAGNA-ChIP MEME
MAX CH12
IC: 7.93 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
G
C
A
C
G
C
A
C
T
5
C
G
G
A
T
T
C
A
G
A
G
T
C
USF; N-Myc; c-Myc:Max;
PHO4; Max primary;
Arnt; GBP; Max; PIF3;
MyoD; Tcfe2a secondary;
Max secondary;
Lmo2complex; SREBP-
1; Bhlhb2 secondary; RAV1
IC: 7.79 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
A
C
G
T
A
A
G
C
C
T
G
A
5
C
A
G
T
A
C
T
G
A
T
C
G
A
G
C
T
USF; Max primary; c-
Myc:Max; PIF3; N-Myc;
Arnt; PHO4; Max; GBP;
MyoD; Sn; Lmo2complex;
SREBP-1; Tcfe2a secondary;
Zscan4 primary;
Max secondary; Tal-
1beta:ITF-2; Tal-
1beta:E47; Tal-1alpha:E47;
Tcfe2a primary
wgEncodeSydhTfbsMelMaxIggrabPk
MAX MEL
IC: 8.44 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
T
A
T
G
C
C
T
A
G
5
G
A
T
T
G
A
T
C
G
A
G
T
C
10
G
T
C
T
G
C
G
A
T
A
C
G
C
G
T
A
15
C
T
G
c-Myc:Max; Max primary;
Arnt; USF; PIF3; N-Myc;
Max; Bhlhb2 secondary;
Bhlhb2 primary;
PHO4; GBP; E47;
MyoD; Tcfe2a primary;
SREBP-1; HTF; RAV1;
Max secondary; Sn; GR
IC: 8.4 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
5
C
T
G
A
A
T
G
C
10
G
A
C
G
T
A
G
A
T
C
C
A
G
A
G
T
15
C
G
c-Myc:Max; Max primary;
Arnt; Max; Bhlhb2 primary;
USF; N-Myc; PHO4;
PIF3; Bhlhb2 secondary;
GBP; SREBP-1; MyoD;
Sn; Max secondary;
Tcfe2a primary;
Myf6 primary; E47; Nkx2-
2 2823.1; Hairy
wgEncodeCaltechTfbsC2c12Sc12732FCntrl32bE2p24hPcr2xPkRep1
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MYOG C2C12
IC: 9.93 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
G
C
C
T
A
G
C
C
T
A
G
5
A
G
C
C
G
A
G
C
T
A
C
G
10
G
C
C
A
T
A
T
C
G
A
T
G
C
C
T
15
A
T
C
G
Ascl2 primary; E47;
Lmo2complex; AP-
4; Myf6 primary;
MyoD; Zic1 secondary;
Zic2 secondary;
Tcfe2a secondary;
Tcfe2a primary;
Zic3 secondary; Sn; HEN1;
AREB6; Myf6 secondary;
Tgif1 2342.2; Tal-
1alpha:E47; RAV1; Tal-
1beta:E47; Pknox2 3077.2
IC: 9.96 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
C
T
G
C
A
G
C
T
A
5
C
G
T
A
G
C
C
A
T
C
A
T
G
T
G
C
10
A
C
T
A
T
C
G
A
G
C
A
G
C
A
G
C
15
G
C
Ascl2 primary; AP-4;
Lmo2complex; E47; HEN1;
MyoD; Myf6 primary;
Tcfe2a primary; AREB6;
Tcfe2a secondary; Sn;
Tgif1 2342.2; Tal-
1alpha:E47; Zic1 secondary;
Pknox2 3077.2;
Zic3 secondary; Gfi-1; Tal-
1beta:E47; Zic2 secondary;
Tgif2 3451.1
wgEncodeCaltechTfbsC2c12Sc12732FCntrl32bE2p60hPcr2xPkRep1
MYOG C2C12
IC: 10.49 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
G
A
T
C
A
G
T
A
C
G
T
C
G
A
5
T
C
A
GCTATAGATGC
10
C
G
A
T
T
A
C
G
C
T
G
T
A
G
C
G
C
T
A
15
A
T
C
G
Myf6 primary;
Ascl2 primary; E47; AP-4;
MyoD; Tcfe2a secondary;
Tcfe2a primary;
Lmo2complex; HEN1;
Sn; Tal-1beta:E47; Tal-
1beta:ITF-2; AREB6;
RAV1; Tal-1alpha:E47;
c-Myc:Max; USF;
Tgif1 2342.2; myogenin/NF-
1; Mybl1 secondary
IC: 10.44 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
G
C
A
G
T
A
T
C
G
G
A
C
5
T
C
C
T
A
T
C
G
T
C
A
T
10
T
C
G
A
G
T
C
A
G
C
T
A
T
G
C
A
G
T
C
15
A
G
C
T
Myf6 primary;
Ascl2 primary; E47; AP-4;
Lmo2complex; MyoD;
Tcfe2a primary; HEN1;
Tcfe2a secondary; Sn; Tal-
1beta:E47; Tal-1beta:ITF-2;
Tal-1alpha:E47; AREB6;
RAV1; USF; Tgif1 2342.2;
c-Myc:Max; Arnt; myo-
genin/NF-1
wgEncodeCaltechTfbsC2c12Sc12732FCntrl50bE2p7dPcr1xPkRep1
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MYOG C2C12
IC: 12.31 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
A
G
C
G
A
C
G
A
5
G
CAAGAGCAT
10
C
G
A
T
G
C
Ascl2 primary;
Myf6 primary; Sn;
MyoD; AP-4; HEN1;
E47; Lmo2complex;
Tcfe2a secondary; Tal-
1beta:ITF-2; myo-
genin/NF-1; Tal-1alpha:E47;
RP58; Tcfe2a primary;
Myf6 secondary;
Tgif1 2342.2; Tal-1beta:E47;
AREB6; Tgif2 3451.1;
Pknox2 3077.2
IC: 12.26 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
A
G
C
G
A
C
G
A
5
G
A
CATAGAGCT
10
G
A
T
G
C
Ascl2 primary;
Myf6 primary; Sn;
MyoD; AP-4; HEN1;
E47; Lmo2complex;
Tcfe2a secondary; myo-
genin/NF-1; Tal-1beta:ITF-2;
Tal-1alpha:E47; RP58;
Tcfe2a primary; Tal-
1beta:E47; Myf6 secondary;
Tgif1 2342.2; AREB6;
Pknox2 3077.2; Tgif2 3451.1
wgEncodeCaltechTfbsC2c12Sc32758FCntrl32bE2p24hPcr2xPkRep1
MYOD1 C2C12
IC: 12.35 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
A
C
T
A
A
T
C
G
5
CTGCTAGCT
10
A
T
C
G
A
T
G
C
Ascl2 primary;
Myf6 primary; MyoD;
HEN1; Sn; AP-4;
Lmo2complex; E47;
Tcfe2a primary; Tal-
1beta:ITF-2; Tal-1alpha:E47;
myogenin/NF-1; Tal-
1beta:E47; RP58;
Tcfe2a secondary;
Myf6 secondary; RAV1;
AREB6; Tgif1 2342.2; Adf-1
IC: 12.39 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
A
G
A
G
C
C
G
A
C
G
A
5
C
T
A
T
A
GGC
A
T
10
G
A
T
G
C
Ascl2 primary;
Myf6 primary; MyoD;
Sn; HEN1; AP-4;
E47; Lmo2complex;
Tcfe2a primary; Tal-
1beta:ITF-2; Tal-
1alpha:E47; myogenin/NF-
1; Tcfe2a secondary;
RP58; Tal-1beta:E47;
Myf6 secondary; AREB6;
RAV1; Tgif1 2342.2;
Pknox2 3077.2
wgEncodeCaltechTfbsC2c12Sc32758FCntrl32bE2p60hPcr2xPkRep1
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MYOD1 C2C12
IC: 11.58 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
T
C
G
G
C
C
C
G
A
5
C
C
T
A
A
T
C
G
A
C
G
T
10
T
G
G
T
C
G
T
C
C
A
G
C
T
15
T
G
C
Ascl2 primary;
Myf6 primary; MyoD;
E47; Lmo2complex; Sn;
AP-4; Tcfe2a primary;
HEN1; Tcfe2a secondary;
Mybl1 secondary;
Myb secondary; Tal-
1beta:ITF-2; Tal-
1alpha:E47; Tal-1beta:E47;
Myf6 secondary; RAV1;
c-Myb; c-Myc:Max; AREB6
IC: 11.29 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
CC
G
T
C
A
T
C
G
5
T
A
C
A
T
C
G
G
T
C
G
T
C
10
G
T
A
C
A
G
T
C
Ascl2 primary; MyoD;
Myf6 primary; Sn; HEN1;
E47; AP-4; Lmo2complex;
Tcfe2a secondary;
Tcfe2a primary;
RAV1; Tal-1alpha:E47;
Tgif1 2342.2; Tal-1beta:ITF-
2; myogenin/NF-1; AREB6;
Myb secondary; Tal-
1beta:E47; USF; c-Myb
wgEncodeCaltechTfbsC2c12Sc32758FCntrl32bPcr2xPkRep1
MYOD1 C2C12
IC: 10.82 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
A
G
GC
G
A
C
G
A
5
T
G
C
G
ATAGAGCAT
10
G
T
C
G
Myf6 primary;
Ascl2 primary; MyoD;
Sn; E47; AP-4; HEN1;
Tal-1beta:ITF-2; Tal-
1alpha:E47; Lmo2complex;
myogenin/NF-1;
Tcfe2a primary;
Tal-1beta:E47;
Tcfe2a secondary; RP58;
AREB6; Myf6 secondary;
RAV1; Tgif1 2342.2; USF
IC: 10.75 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
G
A
C
G
A
G
C
G
A
5
C
A
T
G
A
G
C
A
TG
Ascl2 primary;
Myf6 primary; MyoD;
AP-4; E47; Sn;
myogenin/NF-1; Tal-
1alpha:E47; Tcfe2a primary;
Lmo2complex; HEN1;
Tgif2 3451.1; Tgif1 2342.2;
Tal-1beta:ITF-2;
Pknox2 3077.2; Tal-
1beta:E47; Mrg1 2246.2;
Meis1 2335.1; AREB6;
Mrg2 2302.1
wgEncodeCaltechTfbsC2c12Sc32758FCntrl50bE2p7dPcr1xPkRep1
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MYOD1 C2C12
IC: 13.04 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
A
C
G
G
A
C
T
C
G
A
5
T
C
A
G
C
G
C
G
A
C
G
AC
10
AAGAGCATG
15
A
T
G
C
Ascl2 primary;
Myf6 primary; HEN1;
MyoD; Sn; AP-4;
E47; Lmo2complex;
Tcfe2a secondary;
Tgif1 2342.2;
Tcfe2a primary;
Myf6 secondary; c-
Myb; Tal-1beta:ITF-2;
Pknox2 3077.2; RP58; Tal-
1alpha:E47; Tal-1beta:E47;
Eomes secondary; AREB6
IC: 12.89 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
C
A
G
A
G
C
T
C
G
A
5
T
C
A
G
A
C
G
C
G
A
C
G
AC
10
AAG
A
G
C
A
TG
15
A
T
G
C
Ascl2 primary;
Myf6 primary; HEN1;
MyoD; Sn; AP-4;
E47; Tcfe2a secondary;
Lmo2complex;
Tgif1 2342.2;
Tcfe2a primary; c-
Myb; Myf6 secondary;
Pknox2 3077.2; RP58; Tal-
1beta:ITF-2; Tal-1alpha:E47;
Tal-1beta:E47; AREB6;
myogenin/NF-1
wgEncodeCaltechTfbsC2c12SrfFCntrl32bE2p24hPcr2xPkRep1
SRF C2C12
IC: 8.84 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
G
T
C
T
G
C
A
G
A
C
T
A
C
G
T
5
C
T
G
C
A
T
C
G
A
T
G
A
C
T
10
G
C
T
A
G
C
T
G
C
T
A
C
G
A
T
A
G
15
T
A
C
G
SRF; Srf primary; AG;
YY1; AGL3; TATA;
Tbp secondary; MCM1;
GATA-1; Msx-1
IC: 8.84 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
G
T
A
C
G
A
C
T
A
C
T
G
C
5
A
G
C
G
T
C
G
C
A
T
C
G
A
T
G
C
T
A
10
A
C
T
G
C
A
T
G
C
A
T
C
A
G
T
A
C
G
15
G
T
A
C
SRF; Srf primary; AG;
AGL3; YY1; MCM1;
Tbp secondary; TATA;
GATA-1; Abd-B;
Tcf3 secondary
wgEncodeSydhTfbsCh12TbpIggmusPk
TBP CH12
IC: 7.74 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
C
G
C
A
T
C
G
A
T
5
G
C
T
G
T
C
C
G
T
A
G
C
C
A
T
10
T
G
C
A
T
C
C
T
G
T
A
G
C
15
A
T
C
Gabpa secondary;
Sox12 secondary
IC: 6.81 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
A
G
C
T
G
A
C
T
A
G
G
C
A
5
G
T
A
C
T
A
G
C
A
G
G
A
C
C
G
T
A
10
T
A
G
C
G
T
A
A
C
G
G
C
T
A
T
C
A
G
15
C
T
A
G
Pax-4; cap;
Gabpa secondary;
Irf3 secondary
wgEncodeSydhTfbsMelTbpIggmusPk
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TBP MEL
IC: 8.38 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
C
G
T
C
T
G
C
AA
C
5
C
A
T
A
G
T
G
C
A
A
T
C
G
G
A
T
C
10
A
G
T
C
T
G
C
A
A
G
C
T
A
G
T
C
G
C
A
T
15
A
G
T
C
AP-2rep; CDC5; AP-1; Pax-
4; NF-E2; RAV1
IC: 8.06 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
G
C
G
A
T
A
C
G
T
A
5
A
G
A
G
C
G
T
A
C
C
G
A
G
10
T
G
A
C
T
A
G
C
A
C
15
C
CDC5; Gfi-1; AP-1; GCN4;
v-Maf; TCF11:MafG;
myogenin/NF-1
wgEncodeCaltechTfbsC2c12Tcf3FCntrl32bE2p5dPcr2xPkRep1
TCF3 C2C12
IC: 11.32 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
C
A
G
C
G
A
5
C
T
C
A
T
A
C
G
G
C
C
T
10
T
C
G
A
T
G
C
C
G
A
T
T
A
G
C
A
C
G
T
15
A
T
G
C
Ascl2 primary;
Myf6 primary; MyoD;
E47; Lmo2complex; AP-
4; Sn; Tcfe2a secondary;
Tcfe2a primary; Tal-
1alpha:E47; HEN1;
Tal-1beta:ITF-2; Tal-
1beta:E47; Myf6 secondary;
Myb secondary;
Tgif1 2342.2; AREB6;
Mybl1 secondary; RAV1;
Arnt
IC: 11.02 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
A
T
C
G
G
C
G
T
C
ACG
5
A
T
C
G
C
T
T
C
G
G
C
T
G
T
C
Ascl2 primary; MyoD;
AP-4; Tgif1 2342.2;
HEN1; Lmo2complex;
Myf6 primary; Sn;
Tgif2 3451.1; Meis1 2335.1;
Pknox2 3077.2;
Tcfe2a primary;
Mrg1 2246.2; E47;
Mrg2 2302.1;
myogenin/NF-1;
Tcfe2a secondary;
Pknox1 2364.2; TGIF;
AREB6
wgEncodeCaltechTfbsC2c12Usf1FCntrl50bE2p60hPcr1xPkRep1
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USF1 C2C12
IC: 12.16 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
G
A
T
C
A
G
G
A
C
TC
5
T
A
G
T
C
C
A
G
G
C
A
TG
10
C
T
A
G
A
G
C
T
A
T
G
C
USF; Arnt; SREBP-
1; Bhlhb2 primary; c-
Myc:Max; Max; GBP; N-
Myc; PIF3; Max secondary;
Max primary; RAV1; XBP-
1; Hairy; PHO4; MyoD;
bZIP911; Rara primary;
ATF6; AREB6
IC: 12.0 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
C
G
A
G
A
T
CC
5
C
T
A
G
T
C
C
A
GTG
10
T
C
G
A
G
A
T
C
USF; Arnt; SREBP-1;
Bhlhb2 primary; GBP;
c-Myc:Max; PIF3; Max;
N-Myc; Max secondary;
Max primary; RAV1;
bZIP911; XBP-1;
PHO4; MyoD; Hairy;
Rara primary; ATF6;
CF1/USP
wgEncodeCaltechTfbsC2c12Usf1FCntrl50bPcr1xPkRep1
USF1 C2C12
IC: 12.4 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
C
T
A
G
T
C
A
G
A
G
C
TC
5
AAGTCCAGCAGTCG
10
C
T
A
G
A
G
C
T
A
T
G
C
USF; Arnt; SREBP-
1; Bhlhb2 primary; c-
Myc:Max; Max; GBP; N-
Myc; PIF3; Max secondary;
Max primary; XBP-1;
RAV1; Hairy; bZIP911;
Rara primary; MyoD;
Rxra primary; PHO4;
CF1/USP
IC: 12.34 bits
WebLogo 3.2
0.0
1.0
2.0
b
it
s
T
A
C
G
T
C
G
A
G
A
T
C
G
C
5
G
C
T
A
G
T
C
T
C
A
GTG
10
T
C
G
A
A
G
T
C
G
A
T
C
USF; Arnt; Bhlhb2 primary;
SREBP-1; c-Myc:Max;
Max; GBP; N-Myc;
PIF3; Max secondary;
Max primary; XBP-
1; Rara primary;
RAV1; bZIP911; Hairy;
Rxra primary; CF1/USP;
Nr2f2 primary; MyoD
1.3.4 LASAGNA is Simple and Effective
Unlike MEME and similar methods, the order in which the input sequences
are aligned is crucial to LASAGNA and ClustalW. ClustalW relies on a guide
tree based on pairwise alignments to decide the order. LASAGNA, on the
other hand, depends on the length of a sequence and its similarity to the
partial alignment. LASAGNA-ChIP is well-suited for a TF whose shortest
60
site misses the core or contains only a fraction of it. We, however, observed
no significant difference between LASAGNA and LASAGNA-ChIP on TF-
BSs in the TRANSFAC Public database. This is because, for these TFBSs, a
shortest site often fully contains the core. Hence, our assumption holds true
in general.
For ChIP-seq data, the assumption that short sequences contain less irrele-
vant bases flanking the core may not hold. However, we observe that, under
the one-per-sequence model, LASAGNA-ChIP performed comparably well
to MEME in aligning ChIP-seq peak sequences. We attempted other orders
such as from the longest sequence to the shortest one and found that aligning
the shortest sequence first does have its advantage (data not shown). Also,
we note that, for 11 out of 38 experiments, the peak sequences are all at least
100 bp (see Table 1.3.7) and hence all the peak sequences are 100 bp long
after clipping. This implies that LASAGNA-ChIP is capable of handling
sequences of the same length.
LASAGNA-ChIP, MEME and methods alike produce gapless alignments
and do have their limits. When a TF binds to two cores separated by a
variable-length spacer, these methods are expected to align the canonical
TFBSs containing spacers of the most prevalent length. These binding pat-
61
terns are also known as two-block motifs. Gapped alignment or explicit
modeling [8] is needed to correctly align TFBSs of this nature.
1.4 Conclusions
We proposed LASAGNA, a novel alignment algorithm specifically designed
for aligning variable-length transcription factor binding sites. Cross-validation
results on 189 TFs and 4771 TFBSs indicated that LASAGNA significantly
outperformed ClustalW2 (p-value: 1.22× 10−15) and MEME (p-value: 3.55×
10−15). This is because LASAGNA was specifically designed for aligning
variable-length TFBSs. Based on the success of LASAGNA, we devel-
oped LASAGNA-ChIP, which is capable of handling sequences produced by
ChIP-chip and ChIP-seq experiments. While ClustalW2 is better suited for
producing structurally correct alignments, LASAGNA-ChIP, MEME and
methods alike can be used to align sequences produced by ChIP-chip or
ChIP-seq experiments.
We compared LASAGNA-PSSM, the PSSM method dependent on LASAGNA,
to SiTaR, an alignment free TFBS search method. Cross-validation exper-
iments were conducted on 1751 TFBSs of 90 TFs for both methods. The
results showed that, at fixed recall rates, LASAGNA-PSSM is significantly
more precise than SiTaR (p-value: 2.66 × 10−8). The recall-precision curve
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showed that our method is constantly more precise at any recall rate or more
sensitive at any precision.
We conclude that the LASAGNA algorithm is simple and effective in align-
ing variable-length binding sites. It has been integrated into a user-friendly
webtool for TFBS search called LASAGNA-Search. The tool currently stores
precomputed PSSM models for 189 TFs and 133 TFs built from TFBSs in
the TRANSFAC Public database (release 7.0) and the ORegAnno database
(08Nov10 dump), respectively. In the future, more sources of experimen-
tally validated TFBSs such as the PAZAR database will be incorporated into
the webtool, making variable-length TFBSs more accessible to scientists in
the field.
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Chapter 2
LASAGNA-Search: A User-friendly Webtool for
Transcription Factor Binding Site Search and
Visualization
2.1 Background
In this chapter, we describe a user-friendly webtool named LASAGNA-
Search for transcription factor binding site search. We use the term position-
specific weight matrix (PWM) to refer to an 4 × l matrix described in the
introduction chapter, where l is the length of binding sites of the TF of inter-
ests. The term position-specific scoring matrix (PSSM) is hence used to refer
to the method that scores binding sites based on a PWM or an alignment.
A typical TFBS search webtool takes a PWM and a promoter sequence as
inputs and outputs putative binding sites. Many webtools implement use-
ful features in addition to this basic function. Some tools accept variable-
length binding sites [69, 24, 3] instead of a PWM. Some tools offer precom-
puted models built from PWMs or TFBSs so users do not need to collect
PWMs or TFBSs to use a tool [67, 10, 13, 82, 78, 31]. Some tools adopt
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a TFBS search method that exploits position dependence [69, 67]. Some
tools offer promoter sequence retrieval or integrate a sequence retrieval tool
[67, 83, 2, 82, 78]. For result visualization, the MAPPER2 database [67] sup-
ports visualizing hits in the UCSC Genome Browser [19] for three species.
It is also desirable to visualize the predicted binding specificities as a gene
regulatory network (GRN) [31]. Not all of these useful features however are
available at one single webtool.
To incorporate all the aforementioned useful features, we implemented
LASAGNA-Search: a webtool for TFBS search and visualization. LASAGNA-
Search accepts variable-length TFBSs in addition to PWMs. It offers 1792
precomputed models based on TFBSs and PWMs collected from the TRANS-
FAC Public, JASPAR, ORegAnno and UniPROBE databases. Its search
module exploits position dependence for a TFBS-based model whenever
performance gain is indicated by cross-validation. Automatic promoter se-
quence retrieval is supported for 15 species at LASAGNA-Search, which
enables visualization of search results in the UCSC Genome Browser for
the 15 species. Search results can also be visualized along promoter se-
quences locally at LASAGNA-Search for any species. Finally, a GRN can be
constructed from search results and visualized locally with various options.
2.2 Materials and Methods
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Figure 2.2.1: Architecture of LASAGNA-Search
The search module of LASAGNA-Search takes TF models and promoter se-
quences as inputs. TFBS-based collections contain precomputed TF models
from TFBSs, while PWM-based collections include precomputed TF models
from PWMs. The alignment module aligns user-provided (variable-length)
TFBSs and the alignment may be manually trimmed before model building.
Users may also input a PWM for model building. Promoter sequences may
be provided by users or automatically retrieved by the promoter retrieval
module using the NCBI Gene ID, the official symbol or an mRNA accession
number of a gene. Results produced by the search module may be displayed
in a HTML or tab-delimited table. LASAGNA-Search offers visualization
of the results as local images, while the results can also be displayed in the
UCSC Genome Browser as custom tracks. A gene regulatory network can
be inferred from search results and visualized locally.
Figure 2.2.1 shows the architecture of LASAGNA-Search. We introduce the
major components in the following sections.
2.2.1 Modules
2.2.1.1 Alignment Module
The alignment module aligns variable-length TFBSs so a model can be built
from the alignment. It implements the LASAGNA algorithm detailed in
Chapter 1 and has been extensively compared to ClustalW2 [45] and MEME
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[3] with favorable outcomes (see Section 1.3.1).
2.2.1.2 Search Module
The search module takes a TF model and a promoter sequence as inputs. The
TF model specifies l, the length of a putative binding site, parameter K, and
gives Mi(u) and Mi, j(u, v) for u ∈ {A, C, G, T}, i ∈ [1, l− k] and j ∈ [i + 1, i + K]
as seen in (1.2.1). Depending on the TF, scores of nucleotide pairs may
contribute to the score of a sequence. This is controlled by a parameter
K ≥ 0, the maximal distance between a nucleotide pair. The value of K is
TF-dependent and is determined by cross-validation. Hence, K is greater
than 0 only if nucleotide pairs improve the search performance for a TF.
Conventionally, it is assume that the first letter of an l-mer is aligned with
the first position of a TF model and the l-mer is scored accordingly. Unlike
the conventional approach, we align an l-mer with a TF model by sliding an
l-mer and its reverse-complement through the model such that the overlap
between the two is at least one nucleotide as described in Section 1.2.4. Using
the framework described in Section 2.3.3, we found that this is significantly
better than the conventional approach for locating TFBSs (see Figure 2.2.2).
Moreover, this approach allows easy scoring of an l-mer by a cluster of TF
models of different widths. Scoring by a cluster of TF models has been
shown to outperform using only the best model in the cluster [62] and hence
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is a feature to be included in the near future.
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Figure 2.2.2: Comparison of Scoring Strategies Using TF Models Collected
by LASAGNA-Search
The search module of LASAGNA-Search (x axis) scores a binding site by
sliding a putative site through a TF model, while the conventional approach
(y axis) does not. The evaluation framework is described in section “Evalu-
ation of precomputed TF models” of the main article. Each point in a plot
corresponds to a TF, whose binding sites can be predicted by more than
one model. The average performance across the models is used to plot the
point. Average precision is used as the performance measure to generate
(A), whereas accuracy is the performance measure for (B).
For each putative binding site or hit, the search module computes the score
and the p-value, the probability of observing a score higher or equal to the
score under a background distribution. We adopt the 0th-order Markov
model, also known as the independent multinomial model, as the back-
ground model. To estimate the background distribution for a PSSMK model,
we consider only the binding sites or PWM used to build the model. We
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adopt this conservative way of estimating the score distribution because it
is harder for a non-binding site to get a low p-value in this distribution.
For K = 0, the exact score distribution can be efficiently computed by con-
volution [36]. However, this is not the case for K > 0 since the score can
no longer be seen as a sum of independent variables. Consequently, we
compute p-values using empirical score distributions. The empirical score
distribution of a model is obtained by scanning random promoter sequences
simulated by the background model. Specifically, we focus on only those
PSSMK scores in the upper 5% and hence scores lower than the 5 percentile
are assigned a p-value of 0.05+. The smallest non-zero p-value is 2.5 × 10−5
and a p-value of 0 implies any number lower than 2.5 × 10−5.
While the p-values are not corrected for multiple testing, they are useful for
ordering hits found by different TF models. To take into account the length
of the promoter sequence in which a hit is found, an E-value is computed
for the hit. An E-value gives the expected number of times a hit of the same
or higher score is found in the promoter sequence by chance. Let L be the
length of the promoter sequence and l be the length of the putative binding
site. E-value = p-value ×(L− l + 1), which is approximately p-value ×L when
L l.
2.2.1.3 Promoter Retrieval Module
Currently, LASAGNA-Search supports retrieving promoter sequences for
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15 species: Homo sapiens, Mus musculus, Rattus norvegicus, Drosophila
melanogaster, Saccharomyces cerevisiae, Caenorhabditis elegans, Caenorhab-
ditis briggsae, Bos taurus, Sus scrofa, Ovis aries, Gallus gallus, Canis lupus
familiaris, Felis catus, Xenopus (Silurana) tropicalis and Danio rerio. Users
may enter the NCBI Gene identifier (ID), the official gene symbol or an
mRNA accession number of a gene to retrieve its upstream promoter re-
gion. The upstream region of a gene is specified by positions relative to
the transcription start site (TSS) obtained from the UCSC Genome Browser
[19]. Information in the NCBI Gene database is used for conversion between
Gene IDs and symbols.
2.2.1.4 Gene Regulator Network Inference
LASAGNA-Search automatically constructs a gene regulatory network based
on search results. A directed edge from a TF model to a gene is established
if at least a significant hit is found in the promoter region of the gene by the
TF model. The lowest p-value of these hits is used to compute the weight on
this edge. That is, the thickness of the edge is proportional to − log p-value.
In case the coding genes of a TF model are known, these genes may be added
to the network with dotted arrows from the genes to the TF model. To sim-
plify the network, the node for a TF model may be removed, leaving only
its coding genes in the network. Figure 2.2.3 shows an example network of
human genes TP53 and MYB. Visualization of gene regulatory networks at
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A B C
Figure 2.2.3: An Inferred Gene Regulatory Network of Human Genes TP53
and MYB
A small gene regulatory network of human genes TP53 and MYB inferred
from scanning the promoters (950bp upstream to 50bp downstream) using
two TP53 TF models and two MYB TF models. Genes are denoted by
green ellipses and TF models are represented by red octagons. (A) The
inferred network containing the 2 genes and the 4 TF models. (B) The
dotted edges from the 2 coding genes to the 4 TF models are established in
this network. (C) The simplified network after removing 4 nodes. These
nodes are removed because the two TP53 TF models are coded by the TP53
gene and likewise for MYB.
LASAGNA-Search is enabled by Cytoscape Web [57]. We describe how the
networks in Figure 2.2.3 were generated in Section 2.3.1.
2.2.2 TF Model Collections
LASAGNA-Search currently offers 6 precomputed TF model collections.
The collections are categorized by the type of data used to build a model.
Table 2.2.9 lists the type and number of models for each collection. To
facilitate gene regulatory network visualization, we mapped TF models to
genes coding for the TFs. The number of models that can be mapped is
also listed in Table 2.2.9 for each collection. Models in the TFBS-based
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Table 2.2.9: Summary of TF Model Collections
Database TypeModelsMapped Models1
TRANSFAC TFBS 189 188
ORegAnno TFBS 133 132
PAZAR TFBS 66 66
TRANSFAC PWM 398 366
JASPAR COREPWM 476 457
UniPROBE PWM 530 524
Total 1792 1733
1Models of TFs whose coding genes were found.
collections were built from unaligned TFBSs, while models in the PWM-
based collections were built from PWMs. We describe the two categories in
the following sections.
2.2.2.1 TFBS-based Collections
We collected experimentally validated transcription factor binding sites
from the TRANSFAC Public database and the ORegAnno database. In
these two collections, binding sites of a TF were not collected across species.
TF models are non-redundant in the sense that a TF of a species has only one
model based on all the available binding sites in a database. The binding
sites of a TF were aligned by the alignment module to build a model. We
built one model for each TF because, for most TFs, the binding affinity can
be explained by only one model [92]. In case a TF recognizes more than
one motif [25]), we rely on database curators to distinguish binding sites
belonging to distinct motifs. Moreover, the TFBS-based collections are com-
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pensated by our PWM-based collections, which offer more than one model
for some TFs.
Binding sites of 5 species were collected from the TRANSFAC Public database
(release 7.0) [59], including Homo sapiens, Mus musculus, Rattus norvegi-
cus, Drosophila melanogaster and Saccharomyces cerevisiae. For each
species, a TF was included in our collection if it contains at least 10 bind-
ing sites. Totally, binding sites for 189 TFs across 5 species were collected.
Although TRANSFAC does build PWMs for TFs, 72 (38.1%) of them do not
have any PWMs in TRANSFAC.
Besides the 5 species present in the TRANSFAC collection, binding sites of
Caenorhabditis elegans and Caenorhabditis briggsae were collected from
the ORegAnno database (08Nov10 dump) [32]. Being an open-annotation
database, ORegAnno allows users to adopt the role of curators and con-
tribute binding sites and other types of annotations to the database. A nice
feature is allowing users to enter a NCBI or Ensembl ID for each gene or
transcription factor mention. This feature allows easy mapping of distinct
mentions of the same TF to a unique database ID so binding sites of a TF
contributed by different users can be easily merged. Nevertheless, many TF
mentions in ORegAnno are not accompanied by a database ID. In this case,
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we automatically assign the NCBI Gene ID to a TF mention by consulting
the NCBI Gene database. We note that this is not always possible since
a TF mention may be the symbol of one gene and a synonym of another
and hence cannot be uniquely mapped. Ambiguity was manually resolved
when a TF mention cannot be uniquely mapped to a NCBI Gene ID. Still,
some TF mentions are protein complexes and hence cannot be identified by a
single gene ID. These mentions were semi-automatically collapsed. Finally,
binding sites of 133 TFs across 7 species were collected, where each TF has
at least 10 binding sites.
The PAZAR database [64] offers an platform for users to start curation
projects. A record stores one annotation for one sequence from either an TF-
gene interaction or gene expression experiment. Hence, binding sites of a
TF can be extracted from TF-gene interaction records in the PAZAR projects.
Since more than one project may curate binding sites of a particular TF, we
aggregated records containing TF-gene interaction information from all the
public projects. All the files in the general feature format dated 20120117
were downloaded. We group TFBSs by TF and species, that is, human TF A
and mouse TF A are considered two TFs.
A binding site was filtered out if it is less than 4 or greater than 1000 bases
long. To verify a binding site, we searched for it in the vicinity of the curated
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genomic location in the reference genome. The binding site was discarded if
it couldn’t be located within 5 bases of the curated location. As we collected
binding sites for a TF across all the public projects in PAZAR, a TFBS may be
curated by more than one project, resulting in multiple copies of the TFBS
in our collection. Therefore, for each pair of overlapping binding sites, we
kept only the shorter one if the overlap is more than 80% of the shorter one
in length. A model was built for a TF if it has at least 10 binding sites.
The LASAGNA-ChIP algorithm [50] was used to align the binding sites of a
TF since some of the projects contain TFBSs identified by ChIP-seq and ChIP-
chip experiments. As reported in [38], about 94% of the actual binding sites
can be located within 50 bases of signal peaks. However, no clipping was
done for sequences produced by ChIP-seq experiments since information
about the signal peak is not available in PAZAR. The new collection contains
66 TF models, 39, 20 and 7 of which are human, mouse and rat, respectively.
As seen in Table 2.2.9, nearly all the TF models in the two collections were
mapped to TF coding genes. Only one model in each collection remains
unmapped due to lack of information in the source databases. They are ETF
(T00270) and MYF in TRANSFAC and ORegAnno, respectively.
2.2.2.2 PWM-based Collections
In addition to binding sites, we also collected position-specific weight ma-
trices (PWMs) from the TRANSFAC Public database, the JASPAR CORE
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database [10] and the UniPROBE database [60]. A PWM is a 4 × l matrix,
where l is the length of binding sites. Each element in column i of a PWM
is usually the count or probability of a nucleotide at position i. PWMs are
valuable resources for various reasons. One reason is that most PWMs in
TRANSFAC and JASPAR were built by domain experts. For instance, some
PWMs in TRANSFAC and JASPAR CORE were based on binding sites of
more than one species because of cross-species conservation (e.g. TRANS-
FAC matrix M00152). Moreover, a PWM in TRANSFAC may be based on
binding sites of more than one TF because of similar binding specificities
(e.g. TRANSFAC matrix M00158). Another reason is that for some tech-
niques no binding sites but only matrices are produced. The UniPROBE
database, for example, stores data from protein binding microarray (PBM)
experiments [6]. The PBM technique assigns a binding specificity score to
each 10-mer sequence variant. Berger and Bulyk [6], however, do not sug-
gest setting a specificity cut-off threshold to report binding sites. Instead,
PWMs are produced by the Seed-and-Wobble algorithm.
From the UniPROBE database, we collected 530 PWMs of 6 species: Homo
sapiens, Mus musculus, Saccharomyces cerevisiae, Caenorhabditis elegans,
Plasmodium falciparum and Cryptosporidium parvum. These 530 PWMs
correspond to 414 non-redundant TFs (proteins or protein complexes). We
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collected 476 PWMs from the JASPAR CORE database, where the PWMs
were categorized into 6 species groups: Vertebrates, Insects, Plants, Fungi,
Nematodes and Urochordates. Finally, 398 PWMs were collected from the
TRANSFAC Public database and grouped into Vertebrates, Insects, Plants,
Fungi, Nematodes and Bacteria.
According to Table 2.2.9, the PWM-based collections contain more un-
mapped TF models than the TFBS-based collections. Lack of information in
the source databases is the major reason. Some matrices such as MA0102.1
and MA0061.1 in the JASPAR CORE database were built from TFBSs of
more than one species but accession numbers of the homologous proteins
are not available. Some matrices in the TRANSFAC and JASPAR CORE
databases have protein accession numbers available, while records of the
corresponding coding genes cannot be found in the NCBI Gene database.
These proteins often belong to species such as Pisum sativum and Triticum
aestivum, which are not as well-studied as model organisms.
2.3 Results and Discussion
In this section, we introduce the user interface, followed by a comparison of
features to existing webtools, and evaluation of precomputed TF models in
LASAGNA-Search and MAPPER2. Finally, we discuss future directions for
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improving LASAGNA-Search.
2.3.1 User Interface
2.3.1.1 Input Page
The LASAGNA-Search input page is divided into three parts, one for TF
model input, one for promoter sequence input and one for result filtering
parameter input. Figure 2.3.1a shows a screenshot of the input page. Two
options are available for result filtering. One is setting a p-value threshold
so that only hits with equal or lower p-values will be reported. The other is
setting k so that only k hits with the highest scores will be reported.
For TF model input, LASAGNA-Search accepts variable-length TFBSs for
model building. Users may input TFBSs in the FASTA format. The TF-
BSs will be aligned on clicking the “Start Searching” button. The PWM
and sequence logo [15] of the automatically trimmed alignment will be
displayed. Users may choose to further trim the alignment or recover pre-
viously trimmed columns. Figure 2.3.1c shows the user interface for TFBS
alignment trimming. In addition to TFBSs, users may input a PWM for
model building. LASAGNA-Search recognizes formats used by JASPAR,
TRANSFAC and UniPROBE.
LASAGNA-Search currently offers two ways of selecting models in the
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TFBS-based and PWM-based collections. One is to browse each model
collection, while the other is to search by keywords for models in all the
collections. To browse a collection, users may click the radio button for the
collection to browse models by species or species group. A model can then
be added to the “shopping cart” by marking the model with a tick. Remov-
ing a tick mark will remove the corresponding model from the “shopping
cart”. To search for models, users may enter one or more keywords and
click the “Search” button. The models found will be displayed in a list and
can be similarly selected or removed (see Figure 2.3.1b for an example). The
number of selected models is displayed on the input page. Users may click
the “Show” button to view these models and remove the unwanted ones.
For promoter sequence input, users may input their own promoter se-
quences in the FASTA format. However, users may retrieve promoter se-
quences by NCBI Gene IDs, gene symbols, or mRNA accession numbers. By
clicking the “Search” button, LASAGNA-Search will display the matching
promoters. Figure 2.3.1d shows the promoters found by keywords CCND1
and MYB. Users may choose to examine only promoters of a particular
species. Only the matching human promoters are listed in Figure 2.3.1d
after applying the filter. Promoters are selected in a manner similar to se-
lecting TF models. Finally, users may also select from a list of randomly
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sampled promoters of a chosen species.
2.3.1.2 Result Page
The result page is organized into 5 tabs. The first tab displays hits on all
the promoter sequences, whereas the second tab displays hits pertaining
to one promoter sequence at a time. The third tab shows the gene regula-
tory network inferred from search results. The fourth tab allows importing
previous search results to be merged with the current search results. The
last tab contains the inputs, including the selected TF models, the selected
promoters and the search parameters. Figure 2.3.2 shows an example result
page with the third tab named “Promoter view” showing.
Only hits meeting the specified criterion are reported in the first and sec-
ond tabs. For each hit, the model name, sequence, 0-based position, strand,
score, p-value and E-value are reported. Hits found in the same promoter
sequence can be sorted by model name, sequence, position, strand, p-value
and E-value by clicking the respective column header. By default, the hits
are displayed in a HTML table. Users may click a button on the result page
to obtain the table in the tab-delimited format. Previous search results in the
tab-delimited format can be easily imported to the current search results.
This is particularly useful when additional TFs of interests to the user are
identified after an initial search.
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Users may display the hits along the promoter sequence, where the − log p-
value of each hit is used as the height to plot a box. This allows easy
visualization of the predicted binding sites by a model in the context of
those by the other models. Finally, the hits can be saved in GFF (general fea-
ture format) or the bedGraph format for visualization in the UCSC Genome
Browser [19]. Links are provided for each promoter sequence to automati-
cally create a custom track and redirect users to the UCSC Genome Browser.
Figure 2.3.3 shows a custom track of putative binding sites predicted by
LASAGNA-Search in the context of 4 other relevant tracks.
The automatically inferred GRN can be displayed and manipulated by click-
ing the tab named “Gene regulatory network”. To produce a sparser net-
work, users may set a more stringent p-value than the one used to filter hits.
Users may show only nodes belonging to one or more species listed un-
der “Filter by species” Figure 2.2.3a shows the network after restricting the
species to Homo sapiens. Users may choose to display the TF coding genes
by checking “Map TFs to coding genes”. Figure 2.2.3b shows the resulting
network. While 6 nodes are present in the GRN in Figure 2.2.3b, there are
essentially only 2 genes and their products in the network. When a GRN
involves more genes, it may be desirable to simplify the GRN, replacing the
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TF models with their respective coding genes. Figure 2.2.3c displays the
simplified two node GRN generated by checking “Simple network”. We
note that a GRN can be simplified only after the TF models are mapped to
coding genes.
2.3.2 Comparison of Features to Existing Webtools
LASAGNA-Search was designed to allow users to scan promoters for TFBSs
without leaving the LASAGNA-Search page. Many features of LASAGNA-
Search were developed for user convenience reasons. Hence, without the
knowledge of PWM or TFBS databases and promoter sequence retrieval
tools, users can start searching for binding sites in a promoter sequence and
visualize the hits in the UCSC Genome Browser immediately. There are
several integrative TFBS search webtools available. It is useful to compare
LASAGNA-Search with the existing webtools to better understand the ad-
vantages and disadvantages of LASAGNA-Search and suggest future work
to improve LASAGNA-Search. Table 2.3.10 summarizes the comparison
of LASAGNA-Search to matrix-scan and the search engine of MAPPER2
database for TFBS search.
In terms of input TF models, LASAGNA-Search and MAPPER2 have large
libraries of TF models, while users need to collect PWMs before using matrix-
scan. Users may input a PWM or unaligned TFBSs to LASAGNA-Search for
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model building. On the other hand, while matrix-scan accepts PWMs, both
matrix-scan and MAPPER2 do not accept unaligned TFBSs. For promoter
sequences, all the three tools accept sequences in FASTA, while matrix-scan
handles sequences in 5 additional formats. Automatic sequence retrieval
for matrix-scan is accomplished by interfacing with two tools, “retrieve se-
quence” and “retrieve EnsEMBL sequence”, on the same website. These two
tools are capable of retrieving sequences in a wide range of species and can
be used with any TFBS search tools. LASAGNA-Search and MAPPER2 offer
integrated promoter retrieval tools supporting 7 and 3 species, respectively.
Visualization of predicted binding sites is usually tightly connected with the
promoter sequence retrieval used by a tool. This is because to create a cus-
tom track in the UCSC Genome Browser, the genome build (release version)
and coordinates in the genome must be known for a promoter sequence. For
LASAGNA-Search and MAPPER2, hits found on any promoter sequences
retrieved by the provided tool can be visualized with ease in the UCSC
Genome Browser. Therefore, 7 and 3 species are supported by LASAGNA-
Search and MAPPER2, respectively. Visualizing hits found by matrix-scan
in the UCSC Genome Browser is possible only when the genome build and
coordinates are specified in the FASTA header of the promoter sequence.
Headers of sequences retrieved by the aforementioned two tools, however,
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do not contain the required information enabling visualization of hits in the
UCSC Genome Browser.
Gene regulatory network inference from search results is only available at
LASAGNA-Search among the three integrative webtools. PAINT [31] of-
fers similar function by integrating Match [40] in the TRANSFAC Public or
Professional databases and promoter sequence retrieval for human, mouse
and rat. Compared to PAINT, LASAGNA-Search contains 1792 TF mod-
els from 5 source databases and retrieves promoters for 15 species. The
major difference between LASAGNA-Search and PAINT, however, is that
LASAGNA-Search keeps track of the coding genes of TF models. This is an
important feature because it allows visualization of self-regulation as self-
loops and merging nodes for TF models coded by the same genes.
Finally, it is useful to compare LASAGNA-Search to other relevant webtools.
The MEME Suite [2] offers web interfaces to 4 TFBS search tools with access
to whole-genome promoter sequences. However, these tools have no access
to the PWM database in the suite, nor do they scan promoters of specific
genes and offer visualization of hits. Two tools motivated by evolutionary
conservation are COTRASIF [82] and ReXSpecies2 [78]. COTRASIF collects
138 JASPAR and 398 TRANSFAC PWMs and offer whole-genome Ensembl
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promoter sequences. However, it does not allow selection of gene-specific
promoter sequences nor does it offer visualization. ReXSpecies2, on the
other hand, sources PWMs from JASPAR, scans promoters of specific genes
and allows visualization in the UCSC Genome Browser. However, it focuses
only on human and mouse and selecting individual PWMs requires use of
regular expression-like patterns.
2.3.3 Evaluation of Precomputed TF Models
Since MAPPER2 is the most comparable webtool to LASAGNA, it is useful to
compare the TF model collections offered by LASAGNA-Search and MAP-
PER2 on a whole-genome basis. As the MAPPER2 database stores, for each
TF model, hits from scanning the 10Kbp upstream region of each transcript,
we scanned the same sequences using TF models offered by LASAGNA-
Search. We have no access to the profile hidden Markov models [20] used
by MAPPER2 and the dynamic scanning interface offered by MAPPER2
was not functioning at the time of writing. Fortunately, MAPPER2 allows
downloading of the top-1000 hits for each model. We hence limited the
comparison to the top-1000 hits produced by each TF model.
To evaluate model performance, human and mouse ChIP-seq data from the
ENCODE project [68] was used as the gold-standard. Hence, we consid-
ered models for human and mouse TFs. The comparison was performed
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on a per-TF basis and all the TFs that can be validated were included. Ta-
bles 2.3.11 and 2.3.12 list the ChIP-seq tracks (experiments) by TF for human
and mouse, respectively. We associated each TF with models that can be
used to predict its binding sites. Each of the 1000 hits produced by a model
was checked against the ChIP-seq peaks of the TF. A hit is marked a true
positive if it is completely covered by a peak in at least one experiment as
ChIP-seq peaks are much longer than TFBSs. Otherwise, a hit is marked a
false positive.
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A B
C
D
Figure 2.3.1: Input Page of LASAGNA-Search
User interface of the LASAGNA-Search input page. (A) The input page
when the “Enter known TFBSs” radio button is checked. (A) Selecting
TF models by keyword search. The models matching keywords p53 and
STAT3 are listed in the table. (C) Manual trimming of TFBS alignments.
Automatically trimmed alignment of 11 NF-Y binding sites is presented as
a PWM and a sequence logo for manual trimming. Users may choose to
further trim the alignment or to recover previously trimmed columns by
clicking the 4 buttons on the bottom. (D) Selecting promoters by keyword
search. Promoters found by the keywords CCND1 and MYB are shown in
the table. Only promoters belonging to Homo sapiens are shown.
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All results Promoter view Gene regulatory network Import results Inputs
Homo sapiens chr11 + 69455873 CCND1 NM_053056
Homo sapiens chr6 + 135502453 MYB NM_001130173
Transcripts
Species Chr Strand TSS Symbol mRNA Range
Homo sapiens chr6 + 135502453 MYB NM_001130173 -950 to +50
Homo sapiens chr6 + 135502453 MYB NM_001130172 -950 to +50
Homo sapiens chr6 + 135502453 MYB NM_001161656 -950 to +50
Homo sapiens chr6 + 135502453 MYB NM_001161657 -950 to +50
Homo sapiens chr6 + 135502453 MYB NM_001161658 -950 to +50
Homo sapiens chr6 + 135502453 MYB NM_001161659 -950 to +50
Homo sapiens chr6 + 135502453 MYB NM_001161660 -950 to +50
Homo sapiens chr6 + 135502453 MYB NM_005375 -950 to +50
Hits
gi|224589818:135501503-135502502 Homo sapiens
chromosome 6, GRCh37.p9 Primary Assembly
Name Sequence
Position
(0-based)
Strand Score p-value E-value
AML-1a
(M00271)
AGCGGT 501 - 7.31 0 0
AML-1a
(M00271)
AGCGGT 275 + 7.31 0 0
STAT5A
(M00499)
GAGTTCTG 1 + 8.85 0 0
AML-1a
(M00271)
TGCGGT 125 + 7.2 0.000125 0.124
Finished retrieving results...
LASAGNA-Search Results http://biogrid.engr.uconn.edu/lasagna_search/lasagna...
1 of 1 08/08/2012 02:53 PM
Figure 2.3.2: Result Page of LASAGNA-Search
The LASAGNA-Search result page with the “Promoter view” tab showing.
Users may examine the hits on individual promoter sequences by clicking
the respective title bars. The content for the MYB promoter is shown. The
first table lists the transcripts corresponding to this sequence. The second
table displays the hits found on this promoter sequence.
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Scale
chr6:
200 bases hg19
135,501,800 135,501,900 135,502,000 135,502,100 135,502,200 135,502,300 135,502,400 135,502,500 135,502,600
RefSeq Genes
LASAGNA-Search Predicted TFBSs
H1-hESC H3K4me3 Histone Mods by ChIP-seq Signal from ENCODE/Broad
K562 H3K4me3 Histone Mods by ChIP-seq Signal from ENCODE/Broad
GERP scores for mammalian alignments
MYB
MYB
MYB
MYB
MYB
MYB
MYB
MYB
AP-2(M00189)
NF-kappaB(M00194) c-Myb(M00183)
Tcfap2a(UP00005.Tcfap2a.secondary)
Myb(MA0100.1)
NF-kappaB(M00208)
NFKB1(MA0105.1)
NF-kappaB(p65)(M00052)
NF-kappaB(p50)(M00051)
NF-kappaB(M00054)
NF-kappaB(MA0061.1)
SRF(M00215)
Srf(UP00077.Srf.primary)
SRF(M00186)
E2F(M00024)
E2F1(MA0024.1)
E2F(M00050)
E2F(M00516)
H1-hESC H3K4m3
50 _
1 _
K562 H3K4m3
50 _
1 _
GERP
4.41 _
-8.81 _
0 -
Figure 2.3.3: Visualization of Hits in the UCSC Genome Browser
The hits were produced by scanning the 950bp upstream to 50bp down-
stream promoter region of human gene MYB with 27 TF models. Only
significant hits (p-value ≤ 0.001) were retained. The hits in the GFF format
are displayed in pack mode with 4 other tracks. Hits predicted by the same
TF model are connected by a line. The RefSeq Genes track shows the rel-
ative hit positions to gene MYB. Two histone methylation tracks and the
GERP (Genomic Evolutionary Rate Profiling) track [16] are also shown. The
GERP score is a measure of evolutionary conservation and TFs are known
to preferentially bind motif instances in conserved regions [14]. Histone
methylation has been shown to be the most important factor in predicting
the general binding preference of TFs [21].
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Table 2.3.10
LASAGNA-Search matrix-scan MAPPER2
TF Model
User PWM Yes Yes No
User TFBSs Yes, unaligned,
variable-length
TFBSs.
No Yes, aligned TFBSs.
Model
collection
Yes, 1792
TFBS-based and
PWM-based
models.
Not available Yes, 1017
TFBS-based
models.
Promoter Sequence
Format FASTA FASTA and 5 other
formats.
FASTA
Retrieval tool Yes, built-in for 15
species.
Yes, comprehensive
species coverage by
tools retrieve
sequence and
retrieve EnsEMBL
sequence on the
same website.
Yes, built-in for 3
species.
Search Result
Filtering p-value p-value E-value
Local
visualization
Yes Yes Yes
Visualization
in UCSC
Genome
Browser
Yes, supports 15
species.
Limited. The build,
coordinates and
orientation must be
specified in the
FASTA sequence
header
Yes, supports 3
species.
GRN inference Yes No No
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Evaluating a model based on the top-1000 hits is analogous to evaluating a
search engine based on the top-1000 documents. Therefore, we used average
precision [84] to score a model. This performance measure is widely used
in the information retrieval community and is defined as
∑1000
k=1 P(k)× tp(k)/c.
P(k) gives the precision based on the top k hits (fraction of the top k hits that
are true positives). Indicator tp(k) is 1 if hit k is a true positive. Otherwise,
tp(k) is 0. The denominator c is the portion of upstream regions covered by
peaks in bases and was computed based on all the ChIP-seq experiments
used to validate the model. We also scored each model by accuracy, which
is equivalent to P(1000).
The performance of LASAGNA-Search on a TF was measured by the av-
erage score of the associated models and likewise for MAPPER2. Results
for LASAGNA-Search are listed in Tables 2.3.13 and 2.3.14, while results
for MAPPER2 are listed in Tables 2.3.15 and 2.3.16. Average precision and
accuracy are given in individual columns. Each row presents the perfor-
mance of a model in predicting the binding sites of a TF. Figure 2.3.4 shows
the comparison between LASAGNA-Search and MAPPER2 in terms of av-
erage precision. The same comparison in terms of accuracy is shown in
Figure 2.3.5.
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An outlier corresponding to Mafk is seen in Figures 2.3.4 and 2.3.5. Four
models in LASAGNA-Search and one MAPPER2 model were used to predict
Mafk binding sites (see Tables 2.3.14 and 2.3.16). Interestingly, the best
model of each tool is based on the same TRANSFAC matrix M00037. The
LASAGNA-Search model is a PWM model that has no position dependence
information. The MAPPER2 model, however, is a HMM model, which
considers position dependence. The use of position dependence gave the
MAPPER2 model an edge over the LASAGNA-Search model. The other
three LASAGNA-Search models performed much worse than the best one,
resulting in poor average performance on Mafk. While it is difficult to draw
conclusions on mouse TFs based on 13 TFs, the results on human TFs indicate
that LASAGNA-Search models are significantly better. Overall, we observe
that LASAGNA-Search significantly outperforms MAPPER2, indicating that
models in LASAGNA-Search more accurately predict TFBSs.
2.4 Future Directions
We plan to improve LASAGNA-Search in two aspects, expanding the con-
tent and incorporating useful features. More species will be supported
in automatic promoter retrieval and visualization in the UCSC Genome
browser. To expand our TF model collections, more sources of TFBSs and
PWMs such as the PAZAR database [64] and ChIP-seq data will be consid-
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ered. The GBP score [21] is based on multiple evidence sources including
evolutionary conservation and has been shown to improve prediction of
binding sites. Integration of the GBP scores with the search module will be
investigated.
Using a cluster of TF models to scan a sequence for binding sites has been
shown to outperform using the best model in the cluster [62]. This strategy
will benefit from our large collections of TF models and improve the TFBS
search performance of LASAGNA-Search. Finally, we will enable the search
for two-block motifs [8, 38], that is, binding sites composed of two half sites
separated by variable-length gaps. While plenty of work has been devoted
to de novo two-block motif discovery [8, 56, 54], searching for two-block
motif instances is straight-forward. Using two TF models with or without
gap penalty [8] will be investigated.
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Chapter 3
Searching for Transcription Factor Binding Sites
in Vector Spaces
3.1 Background
In this chapter, we describe searching for transcription factor binding sites
in vector spaces. Specifically, l-mers are placed in the Euclidean space such
that each l-mer corresponds to a vector in the space. With known binding
sites of a TF, we construct a profile vector for the TF. This profile vector can
then be used as a query vector to search for the unknown binding sites in
the space given a similarity measure between two vectors. The vector space
model has long been used in information retrieval (IR) [70, 53]. Under this
model, each document in a collection is embedded in a t-dimensional space.
That is, each document is represented by a t-element vector, where t is the
number of distinct terms present in the document collection or corpus. To
search for documents on a particular topic, a query composed of terms rele-
vant to the topic is constructed. The query can be similarly embedded in the
t-dimensional space. Similarity between the query and a document can then
be measured by measuring the similarity between the two corresponding
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vectors. In the TFBS search problem, the entire genome or the collection of
promoter region sequences corresponds to the corpus, whereas an l-mer is
analogous to a document in IR. On the other hand, a TF is analogous to a
topic, while a TF representation is the analog of a query for the topic.
In this framework, we propose two novel approaches to constructing a query
vector for a TF of interests. They are named the negative-to-positive vector
(NPV) and the optimal discriminating vector (ODV) methods. We compare
the proposed methods to a state-of-the-art method, the ULPB method, as
well as the widely-used PSSM method. Performance of a method is assessed
by cross-validation experiments on two data sets collected from RegulonDB
[27] and JASPAR [65], respectively. Based on the NPV and ODV methods, we
investigate motif subtype identification and show that, consistent with pre-
vious studies [35, 28], identification of motif subtypes improves TFBS search
performance. Independent validation on human ChIP-seq data gives fur-
ther insights into the proposed methods. Finally, we discuss the advantages
of searching for TF binding sites in the proposed framework.
3.2 Methods
3.2.1 Data Sets
To understand the compared methods in this chapter, we experimented on
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Table 3.2.17: Statistics of the E. coli TFs in RegulonDB
Name Length # TFBSs Name Length # TFBSs
MetJ 8 29 Lrp 12 62
SoxS 18 19 H-NS 15 37
FlhDC 16 20 AraC 18 20
Fis 15 206 ArcA 15 93
IHF 13 101 OmpR 20 22
PhoB 20 17 GlpR 20 23
OxyR 17 41 CpxR 15 37
NarL 7 90 CRP 22 249
TyrR 18 19 NarP 7 20
Fur 19 81 LexA 20 40
NtrC 17 17 FNR 14 87
MalT 10 20 PhoP 17 21
ArgR 18 32 NsrR 11 37
prokaryotic as well as eukaryotic transcription factors. The known prokary-
otic TF binding sites were collected from RegulonDB [27] release 6.8. Con-
sidered in [69], this data source contains binding sites of TFs in the E. coli
K-12 genome. We considered a data set of 26 TFs with 17 or more known
binding sites. The filtering criterion ensures that, for each TF, we have
enough examples to learn from. Similar filtering criteria were used in [69].
This data set is summarized in Table 3.2.17.
The known eukaryotic TF binding sites were collected from JASPAR CORE
database (the 4th release) [65]. TFs of Homo sapiens and Mus musculus
were filtered by two criteria. A TF was kept only if it has at least 20 known
binding sites and the length of its binding sites is at least 6 nucleotides.
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The length criterion, arbitrarily chosen, ensures a TF under consideration is
specific enough. This data set is summarized in Table 3.2.18.
3.2.2 Notation
For clarity, we list and define functions and variables used throughout this
chapter.
• fi(u) denotes the probability of observing letter u at position i of a TFBS,
where u ∈ {A, C, G, T}.
• fi, j(u, v) denotes the probability of observing letters u and v at positions
i and j, respectively, where i < j and u, v ∈ {A, C, G, T}.
• fi(v|u) denotes the position-specific conditional probability of observ-
ing v at position i + 1 given u has been seen at position i, where
u, v ∈ {A, C, G, T}.
• f (v|u) denotes the background conditional probability of observing
v given u has been observed at the previous position, where u, v ∈
{A, C, G, T}.
• Iu(·) is the indicator function given by
Iu(v) =

1 if v = u,
0otherwise,
(3.2.1)
where u, v ∈ {A, C, G, T}.
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• Iu1u2(·) is similarly defined as follows:
Iu1u2(v1v2) =

1if v1 = u1 and v2 = u2,
0 otherwise,
(3.2.2)
where u1,u2, v1, v2 ∈ {A, C, G, T}.
• ICi denotes the information content at position i of a binding site.
Information content is closely related to entropy, a measure of uncer-
tainty in information theory. The entropy at position i is given by Ei =
−∑u∈{A, C, G, T} fi(u) log2 [ fi(u)]. When fi(u) = 14 for all u ∈ {A, C, G, T},
Ei attains the maximal entropy of 2 and we are most uncertain about
the letter at position i. ICi is simply defined as
ICi = 2 − Ei = 2 +
∑
u∈{A, C, G, T}
fi(u) log2
[
fi(u)
]
. (3.2.3)
• ICi, j denotes the information content of the position pair (i, j) of a
binding site. Similarly,
ICi, j = 4 +
∑
u,v∈{A, C, G, T}
fi, j(u, v) log2
[
fi, j(u, v)
]
, (3.2.4)
where the maximal entropy of 4 is attained when fi, j(u, v) = 116 for all
u, v ∈ {A, C, G, T}.
3.2.3 Embedding Short Sequences in Vector Spaces
We describe how a short sequence of l nucleotides or an l-mer is placed in
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AGTG……CTCT
1000001000010010……0100000101000001
Figure 3.2.1: Illustration of Embedding a Short Sequence in Vector Space
Each nucleotide in the sequence is converted to 4 indicator variables.
a vector space. Let s be an l-mer and si denote its ith nucleotide. Each nu-
cleotide in s is converted to 4 variables, that is, si is converted to wiIA(si),wiIC(si),wiIG(si) and wiIT(si)
for i = 1, 2, . . . , l. Hence, s is converted to 4l variables, placing s in R4l.
Figure 3.2.1 illustrates the conversion of each nucleotide in an l-mer to 4
variables when wi = 1 for i = 1, 2, . . . , l.
We further consider nucleotide pair (si, s j), where i < j. Only pairs in close
proximity are considered in this study. We consider (si, s j) only if j − i = 1
or 2, i.e., a pair of nucleotides is considered only if they are adjacent or
separated by one nucleotide. Nucleotide pair (si, s j) is similarly converted to
16 variables, wi, jIAA(sis j),wi, jIAC(sis j), . . . ,wi, jITT(sis j), as there are 16 possible
nucleotide pairs, {AA, AC, . . . ,TT}. We use 32l − 48 additional variables to
encode the pairs since there are l− 1 adjacent pairs and l− 2 pairs separated
by one nucleotide. Consequently, considering individual nucleotides and
nucleotide pairs, each l-mer is converted to a (36l − 48)-element vector.
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In this study, we consider two choices of wi’s and wi, j’s. For the first choice,
all the nucleotides and nucleotide pairs are given the same weight, i.e.,
wi = 1 and wi, j = 1 for all i and j. The second one assigns weight to the ith
nucleotide according to the information content at position i. Similarly, it
assigns weight to pair (i, j) according to the information content at this pair
of positions. Specifically, wi =
√
ICi and wi, j =
√
ICi, j for all i and j.
3.2.4 Searching for TFBSs in Vector Spaces
Given a query vector t in space, we score an l-mer s as follows:
Score(s) = sTt, (3.2.1)
where s denote the corresponding vector of s. In other words, the score
of s is obtained by taking the dot-product between s and t. It can be seen
that Score(s) measures the similarity between s and t. Assuming that t
corresponds to an l-mer t, Score(s) counts the number of nucleotides and
nucleotide pairs shared between s and t when wi = 1 and wi, j = 1 for all i
and j. However, we note that t can be any vector in the space and does not
necessarily correspond to an l-mer.
As described above, an l-mer is converted to a (36l − 48)-element vector.
Hence, we use t to search for binding sites in R(36l−48). Our approach offers
great flexibility in that it easily allows searching for binding sites in a lower
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dimensional subspace. By setting all but the first 4l elements in t to zero, we
are essentially searching for binding sites in R4l. In this chapter, we exploit
this advantage and simultaneously search for transcription factor binding
sites in three subspaces. Two of them are R4l and R(36l−48). The third one is
R(16l−12). This subspace is obtained from considering only the first nucleotide
and the l − 1 adjacent nucleotide pairs as in a first order Markov chain.
3.2.5 The NPV Method
We first introduce a simple approach to constructing a query vector. Let
P be the set of n+ binding sites and N be the set of n− non-binding sites
of a particular transcription factor. We embed all the l-mers in P and N in
R(36l−48). We then find the mean binding site vector
µ+ =
1
n+
∑
s∈P
s
as well as the mean non-binding site vector
µ− =
1
n−
∑
s∈N
s.
The query vector t is found by subtracting µ− from µ+, that is, t = µ+ − µ−.
The query vector t can be seen as the vector pointing from the center of the
non-binding site vectors to the center of the binding site vectors. Hence, we
call it the negative-to-positive vector (NPV) method. Figure 3.2.2 illustrates
the idea.
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Figure 3.2.2: Illustration of the NPV Method
The solid arrow represents the negative-to-positive vector µ+−µ−, pointing
fromµ− toµ+. The hallow triangles denote the known binding sites, whereas
the circles represent the known non-binding sites. The center of the binding
site vectors is marked by the solid triangle, while the center of the non-
binding site vectors is marked by the solid circle.
The score of an l-mer s given by the NPV method is therefore
Score(s) = sT(µ+ − µ−) = sTµ+ − sTµ−. (3.2.1)
We can see that it computes the similarity between s and the mean binding
site vector as well as the similarity between s and the mean non-binding site
vector. It then scores s by the difference of the two similarity scores. The
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more similar s is to the mean binding site vector, the higher the score. The
less similar s is to the mean non-binding site vector, the higher the score.
From the perspective of geometry, we note that Score(s) in (3.2.1) is propor-
tional to Score(s)/||t|| , where ||t|| is the length of the query vector t. Moreover,
by virtue of the equality
sTt = ||s|| ||t|| cosθ,
we know Score(s)/||t|| equals the orthogonal projection of s onto t, where θ
is the angle formed by vectors s and t (see Figure 3.2.3 for an illustration).
The computation of Score(s) is therefore equivalent to computation of the
orthogonal projection of s onto t. Similarly, the computation of Score(s) in
(3.2.1) is equivalent to computation of the orthogonal projection of s onto
µ+ − µ−. In Figure 3.2.2, we observe that vector µ+ − µ− is pointing to the
left and, projected onto this vector, most of the binding sites are on the left
of the non-binding sites. This implies that most of the binding sites have a
higher score than the non-binding sites.
3.2.6 The ODV Method
We have described the NPV method, which offers a heuristic way of con-
structing a query vector. We now introduce a way of finding an optimal
query vector β ∈ R(36l−48). Suppose that |P| = n+ and |N| = n−, that is,
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s t
Figure 3.2.3: The Orthogonal Projection of s onto t
It can be seen that the projection of s onto t is equal to Score(s)/||t|| ∝ Score(s).
there are n+ binding sites and n− non-binding sites for a particular TF. Let
P = {s(1), s(2), . . . , s(n+)} and N = {s(n++1), s(n++2), . . . , s(n)}, where s(i) denotes the
ith l-mer in the union of the two sets and n = n+ + n−. We find the optimal β
by solving the following minimization problem:
min
β,b,ξ
1
2
||β||2 + C
n+
n+∑
i=1
ξi +
C
n−
n∑
i=n++1
ξi (3.2.1)
subject to
Score(s(i))
||β|| ≥
b + 1 − ξi
||β|| for s(i) ∈ P, (3.2.2)
Score(s(i))
||β|| ≤
b − 1 + ξi
||β|| for s(i) ∈ N, (3.2.3)
ξi ≥ 0 ∀i. (3.2.4)
The constraint in (3.2.2) ensures that the projection of a TFBS s(i) onto the vec-
tor β, Score(s(i))||β|| , exceeds the threshold
b+1
||β|| . On the other hand, the constraint
in (3.2.3) ensures that the projection of a non-TFBS s(i) onto β stays below the
threshold b−1||β|| . Flexibility is given to the thresholds by introducing ξi’s with
cost captured by the last two terms in (3.2.1). Finally, to clearly distinguish
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TFBSs from non-TFBSs, the squared difference between the two thresholds
( b+1||β|| and
b−1
||β|| ) is made as large as possible. This amounts to maximizing
(
2
||β||
)2
or, equivalently, minimizing 12 ||β||2, which is the first term in (3.2.1). We call
this approach the optimal discriminating vector (ODV) method.
The optimization problem in (3.2.1) is known as a quadratic programming
problem with linear inequality constraints specified in (3.2.2), (3.2.3) and
(3.2.4). There are p + n + 1 variables and 2n constraints, where p = 36l −
48 is the dimension of β. We can see that (3.2.2) and (3.2.3) specify n
constraints whereas (3.2.4) imposes n constraints on the variables. Quadratic
programming [7] is well-studied and hence general solvers are available,
e.g., the OpenOpt framework [43]. To solve this problem, the parameter
C(> 0) is first arbitrarily chosen. A solver then searches for values of β =
(β1, . . . , βp)T, b and ξ = (ξ1, . . . , ξn)T such that the objective function in (3.2.1)
is minimized while the constraints in (3.2.2), (3.2.3) and (3.2.4) are satisfied
simultaneously. It can be seen that an optimal solution to (3.2.1) always
exists since the search space of {β, b, ξ} is never empty. To find a feasible
solution, one can arbitrarily pick β , 0 ∈ Rp and b ∈ R. For s(i) ∈ P, one
can pick ξi ∈ R such that the constraint in (3.2.2) is satisfied. Similarly, for
s(i) ∈ N, one can pick ξi ∈ R such that the constraint in (3.2.3) is met. We
can then compute the value of the objective function as the values of all the
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variables are known. One way to choose the parameter C in (3.2.1) is to
search for C in a range by cross-validation. The parameter is TF-dependent
in general, but experiments showed that a small C = 2−6 will usually suffice
and hence we set C = 2−6 for all the ODV experiments in this study.
3.2.7 The PSSM and ULPB Methods
We briefly describe the ungapped likelihood under positional background
(ULPB) method proposed in [69] and the position-specific scoring matrix
(PSSM) method compared therein. We refer readers to Section 3.2.2 for
functions and variables used here. Consider a specific TF with binding sites
of length l. The PSSM method scores an l-mer s by
l∑
i=1
log
[
fi(si)
]
, (3.2.1)
where si denotes the ith letter in s. We note that usually the ratio fi(si)/ f (si)
is used in place of fi(si), where f (si) is the background probability of si. The
simpler form in (3.2.1) was compared in [69] and hence it serves as a baseline
method in this study.
The ULPB models a TFBS by a first-order Markov chain and models the
background by another first-order Markov chain. The background transi-
tion probabilities are estimated using the entire genome of a species and
hence the ULPB method uses negative examples implicitly. It scores an
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l-mer s by
log f1(s1) +
l−1∑
i=1
log
(
fi(si+1|si)
f (si+1|si)
)
. (3.2.2)
Although ULPB does not consider background probability in the first term of
(3.2.2), the score is approximately the log-likelihood ratio of the two Markov
chains.
The main difference between the PSSM method and the NPV, ODV and
ULPB methods is that the PSSM method does not score nucleotide pairs
nor does it utilize a background distribution. The NPV and ODV methods
explicitly take advantage of negative binding sites, while the ULPB method
does it implicitly by using a background distribution. The flexibility of the
proposed framework allows the NPV and ODV methods to easily search
in subspaces, further distinguishing the PSSM and ULPB methods from the
proposed ones.
3.3 Results and Discussion
3.3.1 Performance Assessment and Evaluation Metrics
The performance of a TFBS search method is evaluated by ν-fold cross-
validation (CV). Consider a TF with n+ TFBSs of length l with flanking
regions on both sides. A set of negative examples, Ntest, called the test neg-
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atives is constructed from the TFBSs of the other TFs with filtering as in
[63]. Another set of negative examples, Ntrain, called the training negatives is
collected from sequences embedding the n+ binding sites. It is comprised of
all the l-mers except for the TFBSs and two neighboring l-mers of each TFBS.
The n+ TFBSs are first divided into ν sets, each of which contains bn+ν c or
bn+ν c + 1 TFBSs. At each iteration of ν-fold CV, one of the ν TFBS sets called
the test TFBS set Ptest is left out. The rest of the TFBSs are therefore called
the training TFBSs. A scoring function is obtained using the training TFBSs
and non-TFBSs randomly sampled from the training negatives, where the
ratio of numbers of non-TFBSs to TFBSs is set to 10. The test TFBSs in Ptest
along with the non-TFBSs in Ntest are then scored by the scoring function.
To score a test sequence, both the forward and reverse strands are scored
and, in case the test sequence is longer or shorter than l, the l-mer pro-
ducing the highest score is used. For each test TFBS t ∈ Ptest, we find its
rank relative to all the non-TFBSs in Ntest. Formally, the rank of t equals
1 + |{s ∈ Ntest|Score(s) ≥ Score(t)}|.
After the ν-fold CV, we end up with n+ ranks, each of which corresponds to
a TFBS. To allow comparison of methods, we use the area under the ROC
curve (AUC) to gauge the performance of a method on the TF. The ROC
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curve is a plot of true positive rate (TPR) against false positive rate (FPR),
displaying the trade-off between TPR and FPR. We refer readers to [23] for an
introduction to this metric. In this study, ν = 10 for all the CV experiments.
For the NPV and ODV methods, the best weight and subspace combination
is obtained at each iteration of the ν-fold CV. Specifically, another (ν−1)-fold
CV is performed on the ν−1 sets of TFBSs to search for the best combination.
3.3.2 Prokaryotic Transcription Factor Binding Sites
To understand the behavior of search methods on prokaryotic TF binding
sites, we conducted 10-fold cross-validation experiments on the 26-TF Reg-
ulonDB data set. The proposed NPV and ODV methods were compared
to the ULPB method [69]. The PSSM method, considered in [69], was also
included for comparison since it served as a simple baseline method.
Figure 3.3.1a shows the plot of area under the ROC curve (AUC) across the
26 TFs for each method. We can see that the ODV method has the best
AUC on 12 out of 26 TFs and the NPV method has the best AUC on 9 out
of 26 TFs whereas the ULPB and PSSM methods have the best AUC on 1
and 4 TFs, respectively. To gauge the relative performance between two
methods, statistical tests [87] were performed on all the 6 pairs of methods.
Figure 3.3.1b shows the p-values of the pairwise comparisons. We first notice
that, consistent with the results in [69], ULPB outperformed PSSM with a
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slightly larger p-value of 0.0679 than the usual 0.05 significance cut-off. As
seen in Figure 3.2.3b, the NPV and ODV methods are significantly better than
the PSSM and ULPB methods. We can see that the ODV method benefited
from optimization albeit minimizing the objective function in (3.2.1) does
not guarantee maximization of the AUC.
3.3.3 Eukaryotic Transcription Factor Binding Sites
Here we compare the proposed NPV and ODV methods to the ULPB and
PSSM methods on eukaryotic TF binding sites. As in the previous section,
we conducted 10-fold cross-validation experiments on the 28-TF JASPAR
data set. Figure 3.3.2a shows the plot of AUC across the 28 TFs for each
method. We can see that both the ODV and NPV methods have the best
AUC on 13 out of 28 TFs while the ULPB and PSSM methods have the best
AUC on 6 and 4 TFs, respectively. All the methods have the best AUC of 1
on MA0149.1 and MA0115, while the ODV, NPV and PSSM methods have
the best AUC of 0.999 on MA0137.2.
Similarly, statistical tests [87] were performed on all the 6 pairs of methods.
Figure 3.3.2b shows that the NPV and ODV methods are significantly better
than the PSSM and ULPB methods. ULPB is significantly better than PSSM,
which is again consistent with the results reported in [69]. Overall, perfor-
mance of the four methods remain unchanged as we shift from prokaryotic
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transcription factors to eukaryotic ones. This implies that a TFBS search
method effective on prokaryotic transcription factors will perform equally
well on eukaryotic transcription factors and vice versa.
3.3.4 Motif Subtype Identification in Vector Spaces
It has been shown that the binding sites of a TF can be better represented by
2 motif subtypes than by a single motif [35, 28]. In search for new binding
sites, two position-specific scoring matrices are used to score an l-mer and
the higher score of the two is assigned to this l-mer. Searching with two
PSSMs was shown to be superior to searching with a single PSSM by cross-
species conservation statistics in these studies.
We demonstrate that motif subtypes can be readily identified once we embed
l-mers in a vector space. The purpose here, however, is not to compare motif
subtype identification algorithms. We adopted a slightly different approach
to motif subtype identification from those in previous work [35, 28], while
the idea is similar. As usual, all the l-mers were first embedded in a vector
space. The known binding sites of a TF were clustered into two subtypes
by the k-means algorithm [17]. Immediately, we have a variant of the NPV
method called the kNPV method, where k = 2 denotes the number of motif
subtypes. The kNPV method first computes the mean vectors of these two
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subtypes, µ+1 and µ+2, and scores an l-mer s by
Score(s) = max
{
sT (µ+1 − µ−) , sT (µ+2 − µ−)
}
,
where µ− is the mean vector of the non-binding sites. Figure 3.3.3 illustrates
the kNPV method.
Similarly, the kODV method scores an l-mer s by
Score(s) = max
{
sTβ+1/||β+1||, sTβ+2/||β+2||
}
,
where β+i is obtained using TFBSs in cluster i, i = 1, 2. Unlike the kNPV
method, the lengths of β+i’s may be very different and hence β+i’s are scaled
to unit vectors so as not to bias the scoring function. We note that the choice
of k = 2 came from previous studies [35, 28]. Generally, k can be greater than
2 or even automatically selected [37]. This however is beyond the scope of
this study and may be investigated in the future.
We assessed the kNPV and kODV methods by 10-fold cross-validation on
both the RegulonDB and JASPAR data sets. Figure 3.3.4 shows the results
in terms of AUC. We observe in Figure 3.3.4a that overall introducing motif
subtypes into the NPV and ODV methods improves the search performance
(p-values: 6.41 × 10−7 and 8.31 × 10−5, respectively). Results in Figure 3.3.4b
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also support this observation (p-values: 1.61 × 10−3 and 3.04 × 10−3, respec-
tively). The kNPV and kODV are comparable on both the RegulonDB and
JASPAR data sets (p-values: 0.197 and 0.47, respectively). These results are
consistent with those reported in [35, 28].
3.3.5 Independent validation on ChIP-seq Data
To evaluate the proposed NPV and ODV methods on the whole genome
scale, we built TF models using TFBSs in the JASPAR database to scan all
the human (build hg19) 1000-base promoter sequences obtained from the
UCSC Genome Browser database [26]. ChIP-seq peaks from the ENCODE
project were also retrieved [68]. Specifically, the wgEncodeRegTfbsClus-
teredV2 table of build hg19 was obtained. We checked TFs in Table 3.2.18
against the annotations and found 14 JASPAR TFs, recognized by 17 anti-
bodies present in the ENCODE annotations. The mapping is listed in the
first 3 columns of Table 3.3.19.
226
Table 3.2.18: Statistics of TFs in the JASPAR Database
Mus musculus
ID Name Length # TFBSs
MA0039.2 Klf4 10 4336
MA0047.2 Foxa2 12 809
MA0062.2 GABPA 11 87
MA0065.2 PPARG::RXRA 15 839
MA0104.2 Mycn 26 85
MA0141.1 Esrrb 12 3613
MA0142.1 Pou5f1 15 1332
MA0143.1 Sox2 15 666
MA0144.1 Stat3 19 830
MA0145.1 Tcfcp2l1 14 3931
MA0146.1 Zfx 20 477
MA0147.1 Myc 10 682
MA0154.1 EBF1 10 21
Homo sapiens
ID Name Length # TFBSs
MA0037 GATA3 6 20
MA0052 MEF2A 10 31
MA0077 SOX9 9 45
MA0080.2 SPI1 7 35
MA0083 SRF 12 26
MA0112.2 ESR1 20 472
MA0115 NR1H2::RXRA 17 22
MA0137.2 STAT1 15 2082
MA0138 REST 19 22
MA0138.2 REST 11 871
MA0139.1 CTCF 11 944
MA0148.1 FOXA1 11 896
MA0149.1 EWSR1-FLI1 17 101
MA0159.1 RXR::RAR DR5 17 23
MA0258.1 ESR2 18 356
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Figure 3.3.3: Illustration of the kNPV Method
The solid arrows represent the negative-to-positive vectors µ+1 − µ− and
µ+2−µ−, pointing fromµ− toµ+1 andµ+2, respectively. The hallow triangles
denote the known binding sites, whereas the circles represent the known
non-binding sites. The centers of the binding site vectors are marked by the
solid triangles, while the center of the non-binding site vectors is marked by
the solid circle.
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For the NPV and ODV methods, the best weight and subspace combination
was found by 5-fold cross-validation on the JASPAR TFBSs, while flanking
genomic sequences of the TFBSs were the sources of negative binding sites.
To assess the 4 compared methods, we considered the part of a ROC curve
where FPR is at most 0.01 and calculated the AUC scaled to between 0 and
1. This is nearly equivalent to allowing at most 10 false positive hits per
promoter on average. As a peak spans about 200 bases, it is considered re-
called when it fully contains a predicted binding site. Similarly, a predicted
binding site must be fully covered by a peak to be a true positive hit.
In Table 3.3.19, we observe that ODV, NPV, ULPB and PSSM produced
the best AUC on 13, 1, 1 and 3 out of 18 tests, respectively. Statistical
tests showed that ODV significantly outperformed the other 3 methods (p-
values≤ 0.0028), NPV significantly outperformed ULPB and PSSM (p-values
≤ 0.0449), and ULPB and PSSM are comparable (p-value: 0.433). We notice
that both NPV and ODV performed worse than the other two methods on
MEF2A. As NPV and ODV both sample negative examples from flanking
sequences of TFBSs, we suspect that this is one example where the flanking
sequences do not represent well the entire promoters. ODV performed
consistently across tests corresponding to the same JASPAR ID such as the
three for CTCF. Examining the best weight and subspace, we can see that
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the subspace agrees on 11 out of 14 TF models, while the weight agrees on
only 7 of them. The latter may be because ODV optimizes the β vector and
hence is less sensitive to the weight used to embed an l-mer.
3.4 Conclusions
In this chapter, we proposed to search for transcription factor binding sites
in vector spaces. The novel NPV and ODV methods were introduced to
construct a query vector to search for binding sites of a TF. We compared
our methods to a state-of-the-art method, the ULPB method, and the widely-
used PSSM method. Cross-validation experiments revealed that the NPV
and ODV methods significantly outperformed the ULPB and PSSM meth-
ods on prokaryotic as well as eukaryotic TF binding sties. Independent
validation on human ChIP-seq data further verified that the NPV and ODV
methods are significantly better than the other compared methods.
One of the advantages of our framework is that it allows one to easily search
for binding sites in various subspaces. Hence, one can search in the best sub-
space for each individual TF since one can hardly find an optimal subspace
for all the TFs. Another advantage is that under the proposed framework
one can readily identify motif subtypes for a TF. Hence, to exploit this ad-
vantage, we introduced the kNPV and kODV methods, immediate variants
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of the NPV and ODV methods. We demonstrated that, consistent with re-
sults in previous studies, kNPV (kODV) significantly improved NPV (ODV)
on the two data sets.
Our future work aims for extending our proposed methods to handling
known binding sites of variable lengths. We will seek to approach this prob-
lem without resorting to multiple sequence alignment, which is notoriously
time-consuming. In the meantime, we will also seek to identify additional
promising subspaces to search for TF binding sites in.
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